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Abstract	   	  
	  
Colorectal	  cancer	  is	  the	  second	  leading	  cause	  of	  cancer-­‐related	  death	  in	  the	  
United	  States.	  	  Adenomatous	  polyposis	  coli	  (APC)	  is	  the	  initiating	  mutation	  in	  80%	  
of	  all	  colorectal	  cancers.	  	  Our	  lab	  is	  focused	  on	  understanding	  functions	  of	  APC	  that	  
promote	  tumor	  suppression	  in	  the	  normal	  intestinal	  epithelia.	  	  As	  a	  protein	  with	  
many	  functions	  in	  the	  cell,	  APC	  is	  both	  nuclear	  and	  cytoplasmic,	  with	  different	  roles	  
in	  maintaining	  cellular	  homeostasis.	  	  In	  the	  cytoplasm,	  APC	  has	  been	  well	  
characterized	  as	  a	  repressor	  of	  Wnt	  signaling,	  a	  pathway	  important	  in	  activating	  
proliferation	  in	  the	  intestine.	  	  Mutation	  of	  APC	  results	  in	  uninhibited	  Wnt	  signaling	  
and	  therefore	  unrestricted	  proliferation	  and	  expansion	  of	  stem	  cell	  populations.	  	  
Though	  APC	  has	  been	  studied	  extensively,	  little	  is	  known	  about	  how	  levels	  of	  APC	  
are	  regulated.	  	  Recently,	  our	  lab	  showed	  a	  double-­‐negative	  feedback	  regulatory	  
mechanism	  between	  APC	  and	  Musashi-­‐1	  (MSI1)	  in	  cell	  culture.	  MSI1	  represses	  
translation	  of	  APC,	  while	  APC,	  via	  its	  role	  as	  a	  negative	  regulator	  of	  Wnt	  signaling,	  
inhibits	  transcription	  of	  MSI1,	  a	  Wnt	  target	  gene.	  	  
	   To	  further	  understand	  the	  role	  of	  the	  APC/MSI1	  double-­‐negative	  feedback	  
loop	  in	  intestinal	  homeostasis,	  I	  isolated	  small	  and	  large	  intestines	  from	  mice	  with	  
germ-­‐line	  knockout	  of	  Msi1	  and	  examined	  differences	  in	  proliferation,	  
differentiation,	  stem	  cell	  populations,	  and	  apoptosis	  in	  the	  small	  intestine.	  In	  the	  
large	  intestine,	  I	  examined	  differences	  in	  proliferation,	  stem	  cell	  populations,	  and	  
apoptosis.	  	  I	  hypothesized	  that	  loss	  of	  Msi1	  in	  the	  intestine	  would	  cause	  an	  increase	  
in	  APC	  protein,	  with	  a	  subsequent	  decrease	  in	  Wnt	  signaling.	  	  This	  decrease	  in	  Wnt	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signaling	  would	  reduce	  the	  rate	  of	  proliferation,	  increase	  differentiation,	  decrease	  
stem	  cell	  populations,	  and	  have	  an	  effect	  on	  apoptosis.	  	  I	  show	  here	  that	  in	  the	  small	  
intestines	  of	  MSI1	  mutant	  mice,	  APC	  protein	  levels	  were	  higher	  and	  Wnt	  target	  gene	  
levels	  were	  lower	  with	  loss	  of	  Msi1.	  	  However,	  proliferation	  and	  differentiation	  of	  
goblet	  cells	  remained	  unchanged.	  	  Stem	  cell	  populations	  were	  reduced	  and	  there	  
was	  a	  decrease	  in	  apoptosis.	  	  In	  the	  large	  intestines	  of	  MSI1	  mutant	  mice,	  APC	  levels	  
and	  Wnt	  target	  genes	  were	  unaffected,	  while	  proliferation	  and	  stem	  cell	  populations	  
were	  decreased.	  	  Based	  on	  this	  evidence,	  the	  APC/Msi1	  feedback	  loop	  may	  play	  a	  
role	  in	  homeostasis	  in	  the	  small	  intestine	  and	  loss	  of	  Msi1	  may	  affect	  a	  different	  
signaling	  pathway	  in	  the	  large	  intestine,	  such	  as	  Notch.	  
	   In	  the	  nucleus,	  APC	  has	  been	  shown	  to	  play	  a	  role	  in	  cell	  cycle	  regulation.	  	  
Our	  lab	  showed	  an	  interaction	  between	  the	  central	  portion	  of	  the	  APC	  protein	  and	  
topoisomerase	  IIα,	  which	  led	  to	  G2	  cell	  cycle	  arrest.	  However,	  whether	  truncated	  
APC	  and	  topo	  IIα	  interact	  in	  colon	  cancer	  cells	  remained	  unknown.	  Here	  I	  present	  
data	  that	  show	  that	  topo	  IIα	  interacts	  with	  endogenous	  truncated	  APC	  containing	  
previously	  defined	  topo	  IIα	  binding	  domains,	  but	  not	  with	  shorter	  APC	  truncations	  
lacking	  these	  binding	  regions.	  
	   The	  studies	  presented	  here	  show	  that	  disruption	  of	  Msi1	  regulation	  of	  APC	  
has	  an	  effect	  in	  the	  small	  intestine	  while	  Msi1	  disruption	  in	  the	  colon	  has	  a	  different	  
effect.	  	  Also,	  longer	  truncated	  APC	  proteins	  endogenous	  to	  colon	  cancer	  cell	  lines	  
interact	  with	  topo	  IIα.	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Colorectal	  cancer	  (CRC)	  is	  a	  major	  contributor	  to	  morbidity	  and	  mortality	  
especially	  in	  the	  United	  States	  where	  it	  is	  the	  second	  leading	  cause	  of	  cancer	  related	  
death	  in	  men	  and	  women	  combined.	  In	  2011,	  it	  is	  predicted	  that	  nearly	  150,000	  
individuals	  will	  develop	  CRC	  and	  50,000	  will	  die	  from	  this	  malignancy.	  	  One	  in	  
twenty	  individuals	  are	  at	  risk	  for	  developing	  CRC	  in	  their	  lifetime	  (American	  Cancer	  
Society(66)).	  	  World-­‐wide	  an	  estimated	  1.2	  million	  new	  cases	  of	  CRC	  are	  diagnosed	  
(1).	  	  
Contributing	  factors	  of	  CRC	  include	  both	  lifestyle	  choices	  as	  well	  as	  genetic	  
factors.	  	  Lifestyle	  choices	  that	  contribute	  to	  CRC	  include	  heavy	  drinking,	  smoking,	  
obesity,	  and	  highly	  processed	  meat	  and	  red	  meat	  intake	  as	  well	  as	  a	  sedentary	  
lifestyle	  (2).	  	  However,	  many	  people	  acquire	  CRC	  who	  do	  not	  meet	  these	  criteria	  (3).	  	  
Also,	  inflammatory	  bowel	  disease,	  including	  Crohn’s	  and	  ulcerative	  colitis,	  play	  a	  
key	  role	  in	  CRC	  with	  one	  third	  of	  CRC	  incidence	  due	  to	  chronic	  inflammatory	  
diseases	  (4).	  	  Genetic	  predisposition	  also	  plays	  a	  large	  role	  in	  contributing	  to	  risk	  of	  
acquiring	  CRC.	  About	  a	  quarter	  of	  people	  with	  family	  members	  that	  have	  CRC	  have	  a	  
higher	  risk	  than	  the	  general	  population	  to	  develop	  CRC	  (5).	  An	  estimated	  30%	  of	  
CRCs	  are	  inherited	  and	  5%	  of	  these	  are	  attributed	  to	  well-­‐characterized	  syndromes	  
(6).	  	  These	  syndromes	  include	  hereditary	  nonpolyposis	  colorectal	  cancer	  (HNPCC),	  
which	  constitutes	  a	  significant	  portion	  of	  inherited	  cases	  and	  is	  due	  to	  mutation	  of	  
mismatch	  repair	  genes.	  A	  smaller	  portion	  can	  be	  attributed	  to	  familial	  adenomatous	  
polyposis	  (FAP),	  which	  results	  in	  the	  patient	  having	  hundreds	  to	  thousands	  of	  
colonic	  polyps	  in	  young	  adulthood	  and	  ultimately	  colon	  cancer	  by	  middle	  age	  (6).	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FAP	  is	  due	  to	  germ-­‐line	  mutation	  of	  tumor	  suppressor	  Adenomatous	  polyposis	  coli	  
(APC).	  	  
The	  specific	  genetic	  defects	  that	  lead	  to	  the	  progression	  of	  CRC	  have	  been	  
well-­‐characterized	  and	  correlate	  with	  the	  morphological	  staging	  of	  the	  disease	  (7).	  
Underlying	  the	  initiation	  of	  CRC	  is	  formation	  of	  a	  benign	  adenomatous	  polyp,	  which	  
is	  caused	  by	  mutation	  of	  both	  alleles	  of	  APC.	  This	  mutation	  is	  usually	  followed	  by	  
mutation	  of	  K-­‐Ras	  or	  B-­‐raf.	  CRC	  precursors	  are	  genetically	  unstable,	  typically	  
possessing	  chromosomal	  instability	  (CIN)	  or	  microsatellite	  instability	  (MSI)	  which	  
are	  mutually	  exclusive	  pathways	  that	  lead	  to	  acquisition	  of	  genetic	  mutations	  (8).	  	  
CIN	  is	  most	  often	  encountered	  with	  FAP	  and	  a	  majority	  of	  sporadic	  CRCs.	  	  In	  about	  
15%	  of	  CRCs	  where	  mismatch	  repair	  (MMR)	  genes	  are	  inactivated,	  MSI	  is	  the	  
mechanism	  for	  further	  genetic	  mutation(3).	  	  In	  either	  case,	  genetic	  instability	  
ultimately	  leads	  to	  inactivation	  of	  p53	  and	  carcinoma.	  
	  
Architecture	  of	  the	  intestinal	  epithelium	  
The	  adult	  intestinal	  mucosa	  is	  composed	  of	  a	  single	  epithelial	  sheet,	  which	  
works	  to	  absorb	  water	  and	  nutrients	  and	  secrete	  protective	  substances	  into	  the	  
lumen	  of	  the	  intestine.	  The	  small	  intestinal	  epithelium	  lines	  the	  two	  structural	  units	  
of	  the	  small	  intestine:	  the	  villi,	  which	  protrude	  from	  the	  luminal	  surface,	  and	  crypts,	  
which	  invaginate	  into	  the	  submucosa.	  The	  epithelia	  is	  composed	  of	  a	  differentiated	  
cell	  population	  including:	  	  enterocytes	  which	  absorb	  nutrients	  and	  water	  from	  the	  
intestine,	  the	  goblet	  cells	  which	  secrete	  a	  protective	  layer	  of	  mucus	  and	  
enteroendocrine	  cells	  which	  stimulate	  secretion	  of	  specific	  digestive	  enzymes.	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Paneth	  cells,	  a	  fourth	  differentiated	  cell	  type,	  secrete	  antimicrobials	  and	  can	  be	  
found	  in	  the	  crypt	  base	  of	  the	  small	  intestine.	  	  Villi	  contain	  the	  differentiated	  cells	  
from	  multiple	  crypts.	  In	  the	  large	  intestine,	  which	  lacks	  villi,	  the	  differentiated	  cells	  
are	  located	  on	  the	  smooth	  luminal	  surface.	  	  The	  differentiated	  cells	  of	  the	  large	  
intestine	  include	  absorptive	  colonocytes	  and	  mucus	  secreting	  goblet	  cells(9).	  
Proliferation	  in	  the	  intestine	  moves	  upward	  along	  the	  axis	  of	  the	  crypt	  to	  the	  
luminal	  surface	  of	  the	  intestine.	  	  Proliferating	  cells	  can	  be	  found	  in	  the	  bottom	  2/3	  of	  
the	  crypt	  whereas	  the	  differentiated	  cells	  are	  found	  along	  the	  top	  1/3	  of	  the	  crypt	  as	  
well	  as	  in	  the	  villi.	  The	  cells	  at	  the	  crypt	  base	  are	  comprised	  of	  stem	  cells	  as	  well	  as	  
Paneth	  cells.	  	  The	  stem	  cells	  divide	  to	  give	  rise	  to	  transit	  amplifying	  cells,	  which	  
move	  up	  the	  crypt	  axis	  and	  further	  divide.	  	  	  Once	  the	  transit	  amplifying	  cells	  reach	  
the	  crypt-­‐villus	  axis,	  they	  differentiate	  to	  become	  the	  functional	  cells	  of	  the	  intestine.	  
The	  exception	  to	  this	  upward	  movement	  of	  differentiated	  cells	  are	  Paneth	  cells	  
which	  move	  to	  the	  base	  of	  the	  crypt	  (10).	  The	  differentiated	  cells	  are	  short-­‐lived	  and	  
undergo	  apoptosis	  and	  are	  shed	  into	  the	  lumen	  or	  engulfed	  by	  neighboring	  cells	  or	  
macrophages	  (11).	  	  This	  process	  of	  cell	  turnover	  in	  the	  intestine	  can	  take	  anywhere	  
from	  3	  days(12)	  to	  5	  days(10)	  in	  mice.	  	  Because	  of	  the	  high	  turnover	  rate	  of	  the	  
intestine,	  maintenance	  of	  intestinal	  homeostasis	  is	  essential	  so	  as	  to	  avoid	  
carcinogenesis	  (for	  overview	  of	  intestinal	  homeostasis	  see	  fig.	  1.1).	  
Underlying	  the	  intestinal	  mucosa	  is	  the	  lamina	  propria	  containing	  various	  
cell	  types.	  One	  of	  these	  cell	  types,	  the	  intestinal	  fibroblast,	  constitutes	  the	  stem	  cell	  
niche	  along	  with	  basement	  membrane	  around	  the	  area	  of	  the	  stem	  cells	  and	  other	  
extracellular	  components	  (13).	  	  The	  myofibroblasts	  concentrate	  around	  the	  crypt	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and	  secrete	  signals	  that	  allow	  for	  epithelial	  proliferation	  and	  differentiation	  (14).	  	  	  
These	  signals	  are	  predominantly	  from	  the	  Wnt,	  Notch,	  BMP,	  and	  Hedgehog	  pathway.	  
Below,	  I	  will	  briefly	  review	  the	  roles	  of	  Wnt	  and	  Notch	  in	  intestinal	  stem	  cell	  
maintenance.	  	  Review	  of	  the	  BMP	  and	  Hedgehog	  pathways	  can	  be	  found	  in	  (10)	  	  
	   Along	  with	  being	  critical	  for	  intestinal	  stem	  cell	  maintenance,	  Wnt	  signaling	  
is	  critical	  for	  the	  maintenance	  of	  the	  whole	  intestinal	  epithelium(7,	  15,	  16)	  and	  
disruption	  of	  Wnt	  signaling	  is	  an	  initiating	  event	  to	  drive	  the	  transformation	  of	  
normal	  intestinal	  mucosa	  to	  adenocarcinoma	  (7).	  	  The	  Wnt	  signaling	  pathway	  is	  
mediated	  by	  phosphorylation	  events	  of	  β-­‐catenin	  as	  determined	  by	  presence	  or	  
absence	  of	  a	  Wnt	  signal.	  	  When	  the	  Wnt	  signal	  is	  absent,	  a	  destruction	  complex	  
composed	  of	  tumor	  suppressor	  adenomatous	  polyposis	  coli	  (APC)	  and	  axin	  will	  bind	  
to	  Β-­‐catenin	  and	  two	  other	  destruction	  complex	  proteins,	  GSK3	  and	  CK1	  will	  
phosphorylate	  Β-­‐catenin.	  	  Phosphorylation	  of	  Β-­‐catenin	  recruits	  the	  E3	  ubiquitin	  
ligase,	  βTrCP,	  which	  will	  ubiquitinate	  Β-­‐catenin,	  leading	  to	  its	  eventual	  degradation	  
by	  the	  proteosome.	  	  When	  the	  Wnt	  signal	  binds	  to	  its	  cognate	  receptor	  which	  
includes	  a	  protein	  from	  the	  Frizzled	  family	  as	  well	  as	  Lrp5/6,	  the	  destruction	  
complex	  is	  inhibited	  from	  binding	  Β-­‐catenin	  by	  as	  yet	  unknown	  mechanisms.	  	  Β-­‐
catenin	  will	  then	  translocate	  into	  the	  nucleus	  where	  it	  will	  activate	  transcription	  
cofactors	  Tcf	  and	  Lef	  and	  Wnt	  target	  genes	  will	  be	  expressed	  (17).	  	  For	  overview	  of	  
the	  Wnt	  pathway	  refer	  to	  fig.	  1.2.	  	  There	  are	  approximately	  50	  known	  Wnt	  target	  
genes	  (Standford.edu	  Wnt	  Homepage(65)).	  	  Normal	  Wnt	  signaling	  allows	  for	  
proliferation	  and	  turnover	  of	  stem-­‐cell	  populations	  whereas	  aberrant	  Wnt	  signaling	  
allows	  for	  continual	  uncontrolled	  renewal	  of	  stem	  cells	  (17).	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   Along	  with	  Wnt	  signaling,	  Notch	  signaling	  has	  been	  implicated	  in	  maintaining	  
the	  undifferentiated	  and	  proliferative	  state	  in	  the	  intestine.	  	  Notch	  also	  helps	  to	  
determine	  cell	  fate	  decisions	  in	  the	  intestine	  by	  specifically	  controlling	  cell	  fate	  
choices	  between	  neighboring	  precursor	  cells.	  	  Notch	  encodes	  a	  transmembrane	  
receptor	  that	  is	  proteolytically	  cleaved	  following	  binding	  to	  ligand	  expressed	  by	  a	  
neighboring	  cell.	  	  This	  cleavage	  event	  is	  followed	  by	  subsequent	  translocation	  of	  the	  
Notch	  intracellular	  domain	  (NCID)	  into	  the	  nucleus.	  The	  NCID	  binds	  a	  
transcriptional	  repressor,	  CSL,	  causing	  it	  to	  become	  an	  activator	  of	  Notch	  target	  
genes.	  	  The	  best	  known	  Notch	  target	  genes	  encode	  Hes	  protein	  which	  acts	  as	  a	  
transcriptional	  repressor	  (10).	  
	   Notch	  signaling	  in	  the	  intestine	  has	  been	  implicated	  in	  the	  decision	  between	  
enterocyte	  and	  secretory	  cell	  lineages	  in	  early	  progenitor	  cells	  (18-­20).	  Upon	  
inhibition	  of	  Notch	  signaling	  via	  gamma-­‐secretase	  inhibitors	  or	  CSL	  removal,	  
proliferative	  cells	  were	  converted	  into	  goblet	  cells(18).	  Additionally,	  overexpression	  
of	  the	  Notch1	  receptor	  in	  all	  epithelial	  intestinal	  cells	  caused	  an	  increase	  in	  
proliferation	  and	  an	  inhibition	  of	  secretory	  lineages	  including	  Paneth,	  Goblet,	  and	  
enteroendocrine	  cells(19,	  20).	  	  	  
Notch	  signaling	  also	  works	  synergistically	  with	  Wnt	  signaling	  to	  activate	  
proliferation	  in	  progenitor	  populations.	  	  Notch1	  was	  found	  to	  be	  expressed	  in	  both	  
stem-­‐cell	  subpopulations	  in	  the	  crypt	  as	  well	  as	  in	  transit-­‐amplifying	  cells	  (19).	  	  	  
And,	  Wnt	  signaling	  has	  been	  implicated	  to	  activate	  Notch	  signaling	  by	  β-­‐catenin	  
transcriptional	  activation	  of	  Notch	  ligand	  in	  colorectal	  cancer	  cells	  (21).	  Also,	  
activation	  of	  Notch	  signaling	  is	  found	  to	  inhibit	  apoptosis	  (22).	  	  	  Finally,	  Msi1	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overexpression	  enhances	  proliferation	  in	  progenitor	  populations	  (23).	  Therefore	  
Wnt	  and	  Notch	  act	  synergistically	  to	  promote	  proliferation	  in	  the	  progenitor	  
compartment	  of	  the	  intestine	  and	  to	  promote	  colorectal	  cancer.	  	  
	  
Intestinal	  Stem	  cells	  
	  
Cancer	  initiating	  mutations	  are	  proposed	  to	  originate	  in	  the	  stem	  cell	  because	  
these	  cells	  have	  the	  capacity	  for	  longevity	  required	  to	  obtain	  the	  necessary	  number	  
of	  mutations	  that	  lead	  to	  cancer(24).	  Stem	  cells	  are	  defined	  as	  having	  four	  
characteristics:	  they	  are	  undifferentiated,	  can	  give	  rise	  to	  all	  cell	  types	  of	  the	  
intestine,	  can	  regenerate	  when	  damaged,	  and	  can	  give	  rise	  to	  new	  stem	  cells	  over	  a	  
long	  period	  of	  time	  (10).	  There	  have	  been	  two	  populations	  of	  stem	  cells	  identified	  in	  
the	  small	  intestine	  that	  meet	  these	  criteria(25).	  	  The	  slow	  cycling	  stem	  cell	  
population	  is	  marked	  by	  Bmi1(26).	  	  These	  cells	  are	  located	  at	  +4	  position	  in	  the	  
crypt	  and	  estimates	  of	  stem	  cells	  in	  the	  +4	  position	  range	  from	  4-­‐6	  cells	  which	  can	  
be	  killed	  by	  small	  doses	  of	  radiation(12,	  27)	  The	  other	  stem	  cell	  population	  is	  
composed	  of	  crypt-­‐based	  columnar	  cells	  marked	  by	  Lgr5	  and	  located	  between	  
paneth	  cells.	  	  These	  cells,	  unlike	  Bmi1+,	  cells	  are	  actively	  cycling	  and	  undergo	  
apoptosis	  only	  with	  high	  dosages	  of	  radiation	  (28).	  	  In	  two	  separate	  mouse	  models,	  
one	  with	  conditional	  loss	  of	  APC	  and	  the	  other	  with	  an	  activating	  mutation	  in	  β-­‐
catenin,	  both	  populations	  of	  stem	  cells	  were	  shown	  to	  initiate	  adenoma	  formation	  
(29,	  30).	  	  Therefore,	  the	  adenoma-­‐initiating	  cells	  appear	  to	  be	  stem	  cells	  and	  
maintenance	  of	  “stemness”	  in	  these	  adenomas	  leads	  to	  initiation	  of	  tumors.	  
	   8	  
Musashi1	  has	  also	  been	  shown	  as	  a	  putative	  stem	  cell	  marker,	  labeling	  both	  
Lgr+	  and	  Bmi1+	  stem	  cell	  populations(31,	  32).	  	  In	  support	  of	  its	  role	  in	  stem	  cells,	  
Msi1	  +	  cells	  were	  seen	  to	  increase	  in	  the	  stem	  cell	  compartment	  of	  the	  crypt	  
following	  irradiation.	  	  However,	  using	  immunohistochemistry,	  Potten	  et	  al,	  also	  
showed	  that	  Msi1	  potentially	  labels	  cells	  above	  the	  stem	  cell	  region	  of	  the	  crypt	  and	  
thereby	  may	  also	  label	  some	  transit	  amplifying	  cells	  (31).	  	  
	  
Musashi-­1	  
Musashi-­‐1	  (Msi1)	  is	  an	  RNA-­‐binding	  protein	  composed	  of	  362	  amino	  acids	  
and	  with	  a	  molecular	  weight	  of	  approximately	  39kDa	  in	  mice	  (33).	  	  Msi1	  was	  first	  
discovered	  to	  be	  important	  for	  development	  of	  adult	  external	  sensory	  organs	  in	  
Drosophila,	  a	  model	  system	  that	  has	  been	  effectively	  used	  to	  understand	  
mechanisms	  that	  control	  asymmetric	  cell	  division	  in	  development.	  Specifically,	  Msi1	  
was	  found	  to	  be	  important	  for	  asymmetric	  divisions	  of	  sensory	  organ	  precursor	  
cells	  (34).	  	  Msi1	  was	  also	  found	  to	  be	  active	  in	  mitotic	  cell	  populations	  in	  neuronal	  
and	  glial	  precursor	  cells	  as	  well	  as	  neural	  stem	  cells	  during	  neurogenesis	  in	  mice	  as	  
well	  as	  in	  ovaries	  and	  the	  small	  intestine	  of	  mice(33).	  	  
Msi1	  acts	  as	  a	  translational	  repressor	  by	  binding	  to	  the	  3’UTR	  of	  target	  RNA	  
and	  competing	  with	  PABP	  interaction	  with	  eIF4a,	  thus	  inhibiting	  formation	  of	  the	  
80S	  ribosome	  complex	  (35).	  Msi1	  is	  key	  in	  maintaining	  cells	  in	  an	  undifferentiated	  
state,	  thereby	  allowing	  for	  cell	  fate	  decisions	  to	  occur	  (22).	  	  Key	  targets	  of	  Msi1	  
translational	  inhibition	  include	  m-­numb	  an	  inhibitor	  of	  the	  Notch	  pathway.	  	  Msi1	  
was	  therefore	  found	  to	  be	  an	  activator	  of	  the	  Notch	  pathway,	  leading	  to	  self-­‐renewal	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of	  neural	  stem	  cells	  as	  well	  as	  a	  non-­‐differentiated	  state(22).	  Msi1	  was	  also	  found	  to	  
be	  a	  translational	  inhibitor	  of	  p21WAF-­‐1,	  a	  cyclin-­‐dependent	  kinase	  inhibitor.	  	  Upon	  
overexpression	  of	  Msi1	  in	  HEK293	  cells	  and	  P19	  neuronal	  differentiating	  cells,	  
proliferation	  was	  found	  to	  increase	  as	  well	  as	  an	  increase	  in	  the	  number	  of	  	  actively	  
cycling	  cells.	  	  Loss	  of	  Msi1	  caused	  a	  premature	  exit	  from	  the	  cell	  cycle	  in	  neural	  
development	  (36).	  In	  both	  numb	  and	  p21WAF-­‐1	  	  translational	  repression	  by	  Msi1,	  
mRNA	  levels	  were	  not	  found	  to	  be	  affected	  (22,	  36).	  	  	  
Msi1	  expression	  has	  been	  correlated	  with	  CRC	  as	  a	  driving	  force	  for	  
tumorigenesis	  and	  as	  a	  marker	  of	  metastatic	  cancer.	  Msi1	  mRNA	  was	  found	  to	  be	  
higher	  in	  human	  colorectal	  adenocarcinoma	  than	  in	  surrounding	  normal	  mucosa	  	  
(31,	  37).	  	  Also,	  Msi1	  expression	  is	  increased	  in	  APCMin/+	  mice	  tumors	  compared	  with	  
normal	  tissue	  (31).	  	  	  	  APCMin/+	  mice	  carry	  a	  truncating	  mutation	  in	  APC	  and	  are	  
commonly	  used	  as	  a	  model	  for	  colorectal	  cancer.	  	  In	  a	  mouse	  xenograft	  model,	  
siRNA-­‐mediated	  knockdown	  of	  Msi1	  led	  to	  inhibition	  of	  tumor	  growth,	  reduced	  
proliferation	  of	  cancer	  cells,	  and	  increased	  apoptosis	  both	  alone	  and	  with	  radiation.	  	  
Also,	  Msi1	  knock	  down	  in	  HCT116	  cells,	  a	  colon	  cancer	  cell	  line,	  resulted	  in	  
increased	  p21WAF-­‐1	  protein	  levels	  and	  cell	  cycle	  arrest.	  	  Notch	  signaling	  was	  found	  to	  
decrease,	  allowing	  for	  a	  subsequent	  increase	  in	  mitosis	  (37).	  	  	  Finally,	  Msi1	  levels	  
were	  found	  to	  be	  an	  important	  prognostic	  indicator	  in	  patients	  with	  colorectal	  
cancer	  both	  in	  the	  primary	  tumor	  and	  as	  an	  indicator	  of	  metastatic	  spread(38).	  
	  
APC	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Familial	  adenomatous	  polyposis	  (FAP)	  is	  an	  autosomal	  dominant	  disorder	  
where	  patients	  develop	  colorectal	  cancer.	  Patients	  with	  FAP	  usually	  acquire	  colonic	  
adenomas	  as	  early	  as	  their	  teenage	  years	  and	  by	  age	  40	  or	  50	  these	  patients	  will	  
have	  colorectal	  cancer.	  	  As	  treatment	  for	  this	  disorder,	  patients	  undergo	  removal	  of	  
the	  colon	  to	  ensure	  that	  the	  hundreds	  to	  thousands	  of	  polyps	  present	  in	  the	  colon	  do	  
not	  give	  rise	  to	  cancer(39).	  	  	  
Germ-­‐line	  mutation	  of	  APC	  was	  first	  linked	  to	  FAP	  .	  	  A	  deletion	  of	  5q21	  was	  
linked	  to	  patients	  with	  FAP	  (40).	  The	  gene	  was	  cloned	  and	  the	  APC	  mutation	  was	  
shown	  to	  be	  heterozygous	  in	  the	  colon	  of	  FAP	  patients	  though	  the	  mechanism	  for	  
initiation	  of	  polyps	  was	  still	  unknown	  (41,	  42).	  	  In	  support	  of	  Knudson’s	  two-­‐hit	  
model	  of	  inactivation	  of	  tumor	  suppressor	  genes,	  Ichii	  et	  al.	  and	  Levy	  et	  al.	  
determined	  that	  loss	  of	  heterozygosity	  or	  mutation	  of	  the	  other	  wild-­‐type	  APC	  allele	  
allowed	  for	  early	  tumorigenesis	  events	  to	  occur(43,	  44).	  The	  APC	  mutations	  in	  
sporadic	  colorectal	  cancer	  have	  been	  found	  to	  be	  identical	  to	  those	  found	  in	  
FAP(45).	  	  	  
	   APC	  has	  been	  shown	  to	  be	  expressed	  ubiquitously	  throughout	  the	  body	  (42)	  
and	  also	  is	  important	  in	  development.	  	  APC	  is	  predominantly	  expressed	  at	  the	  
basolateral	  membrane	  in	  the	  intestine,	  and	  it’s	  expression	  increases	  in	  a	  gradient	  
that	  moves	  up	  the	  length	  of	  the	  crypt	  (46).	  	  Germ-­‐line	  mutation	  or	  knockout	  of	  APC	  
is	  embryonic	  lethal,	  causing	  improper	  anterior-­‐ventral	  morphogenesis	  in	  the	  
embryo	  (Ishikawa,	  2003;	  Moser,	  1995).	  	  Also,	  conditional	  knockout	  of	  APC	  in	  adult	  
mice	  leads	  to	  disruption	  of	  proliferation	  patterns	  in	  the	  small	  intestine	  as	  well	  as	  
abnormal	  differentiation	  of	  small	  intestinal	  cells	  (15).	  	  Though	  APC	  is	  necessary	  for	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development,	  it	  is	  not	  lost	  as	  an	  initiating	  step	  in	  other	  cancers.	  APC	  is	  therefore	  
considered	  a	  gate-­‐keeping	  gene	  in	  the	  intestine,	  providing	  a	  pivotal	  role	  in	  
regulation	  of	  intestinal	  homeostasis(45).	  
	   APC	  is	  a	  multi-­‐domain	  protein	  that	  interacts	  with	  a	  number	  of	  binding	  
partners	  and	  performs	  the	  role	  of	  a	  scaffold	  protein	  in	  Wnt	  signaling.	  	  	  It’s	  2,843	  
amino	  acids	  in	  size	  and	  312	  kDa	  (47).	  	  The	  N-­‐terminal	  region	  of	  the	  protein	  is	  
necessary	  for	  homodimerization,	  and	  in	  colon	  cancers,	  full-­‐length	  APC	  can	  dimerize	  
with	  mutant	  forms	  of	  APC	  (48).	  	  The	  armadillo	  region	  of	  the	  protein	  has	  been	  shown	  
to	  be	  important	  for	  binding	  to	  PP2A	  and	  ASEF-­‐2(49,	  50).	  	  The	  15-­‐amino	  acid	  region	  
and	  20	  amino	  acid	  region	  have	  been	  shown	  to	  be	  important	  for	  β-­‐catenin	  
binding(51-­53),	  though	  the	  20	  amino	  acid	  region	  is	  necessary	  for	  β-­‐catenin	  
downregulation	  (51).	  	  The	  SAMP	  repeats	  located	  between	  20	  amino	  acid	  repeats	  are	  
necessary	  for	  APC	  binding	  to	  axin,	  another	  scaffold	  protein	  in	  the	  destruction	  
complex	  (54).	  For	  a	  diagram	  of	  the	  APC	  protein,	  refer	  to	  fig.	  1.3.	  
Somatic	  mutations	  of	  APC	  that	  occur	  in	  colon	  cancer	  appear	  in	  the	  mutation	  
cluster	  region	  whereas	  germ-­‐line	  mutations	  of	  APC	  are	  found	  throughout	  the	  5’end	  
of	  the	  gene.	  These	  mutations	  are	  typically	  nonsense	  or	  framshift	  mutations	  that	  
result	  in	  the	  truncation	  of	  the	  C-­‐terminal	  half	  of	  the	  protein(55).	  	  Mutations	  disrupt	  
the	  ability	  of	  APC	  to	  bind	  to	  β-­‐catenin	  and	  therefore	  β-­‐catenin	  accumulates	  in	  the	  
nucleus	  and	  control	  of	  Wnt	  signaling	  is	  lost.	  
	   APC,	  a	  predominantly	  cytoplasmic	  protein,	  has	  been	  shown	  to	  have	  a	  nuclear	  
role	  as	  well	  that	  may	  allow	  for	  distinction	  of	  actively	  proliferating	  cells	  (56).	  	  APC	  
has	  been	  shown	  to	  contain	  2	  classic	  nuclear	  localization	  signals	  as	  well	  as	  5	  nuclear	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export	  signals	  that	  allow	  for	  it	  to	  shuttle	  between	  the	  nucleus	  and	  the	  cytoplasm(57-­
59).	  	  	  Full-­‐length	  APC	  appears	  in	  both	  the	  nucleus	  and	  cytoplasm	  in	  normal	  human	  
colonic	  crypts.	  	  In	  human	  polyps	  and	  carcinoma,	  full-­‐length	  APC	  is	  found	  
predominantly	  in	  the	  cytoplasm	  while	  truncated	  APC	  is	  found	  in	  both	  nucleus	  and	  
cytoplasm	  (60).	  	  The	  function	  of	  APC	  in	  the	  nucleus	  has	  been	  thought	  to	  include	  
further	  regulation	  of	  β-­‐catenin	  via	  sequestration	  of	  β-­‐catenin	  from	  TCF/Lef,	  
interaction	  with	  repression	  machinery	  that	  competes	  with	  TCF/Lef	  for	  activation	  of	  
Wnt	  target	  genes,	  and	  facilitation	  of	  nuclear	  export	  of	  β-­‐catenin(56).	  	  APC	  has	  also	  
been	  shown	  to	  have	  a	  potential	  role	  in	  DNA	  repair	  through	  interaction	  with	  binding	  
partners	  polymerase	  B	  and	  PCNA(61).	  	  Another	  potential	  role	  of	  APC	  is	  in	  cell	  cycle	  
regulation	  via	  its	  interaction	  with	  topoisomerase	  IIα	  (62,	  63).	  	  	  
Msi1	  and	  APC	  
Our	  lab	  recently	  demonstrated	  a	  double-­‐negative	  feedback	  loop	  between	  
Msi1	  and	  APC	  (64).	  	  In	  cell	  culture,	  overexpression	  of	  Msi1,	  a	  translational	  inhibitor,	  
was	  shown	  to	  inhibit	  translation	  of	  mRNA	  containing	  the	  APC	  3’UTR	  while	  loss	  of	  
Msi1	  showed	  an	  increase	  in	  APC	  protein	  levels.	  	  Loss	  of	  APC	  lead	  to	  an	  increase	  in	  
Msi1	  protein	  and	  mRNA.	  	  These	  findings	  lead	  to	  a	  predicted	  model	  of	  Msi1	  being	  a	  
direct	  inhibitor	  of	  APC	  translation	  (64).	  	  Msi1	  was	  also	  found	  to	  be	  a	  Wnt	  target	  gene	  
(23).Therefore,	  APC	  via	  inhibition	  of	  the	  Wnt	  pathway,	  is	  an	  inhibitor	  of	  Msi1	  
transcription	  and	  translation.	  
In	  the	  next	  chapter	  of	  this	  dissertation,	  we	  investigated	  the	  role	  of	  	  
Apc/Msi1	  double-­‐negative	  feedback	  regulation	  in	  the	  intestines	  of	  Msi-­‐/-­‐	  mice,	  a	  
mouse	  model	  with	  germ-­‐line	  knockout	  of	  Msi1.	  	  To	  determine	  whether	  loss	  of	  Msi1	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affected	  Apc,	  Apc	  protein	  levels	  were	  examined	  and	  found	  to	  be	  higher	  in	  the	  small	  
intestine	  and	  unchanged	  in	  the	  large	  intestine	  compared	  to	  Msi+/+	  mice.	  	  Wnt	  target	  
gene	  levels	  were	  assessed	  and	  were	  shown	  to	  be	  downregulated	  in	  the	  small	  
intestine	  and	  unchanged	  in	  the	  large	  intestine.	  	  These	  results	  lead	  to	  a	  hypothesis	  
that	  the	  double-­‐negative	  feedback	  loop	  was	  possibly	  more	  prevalent	  in	  the	  small	  
intestine.	  	  Next,	  different	  phenotypes	  related	  to	  Wnt	  signaling	  were	  examined.	  	  In	  
the	  small	  intestine,	  proliferation	  as	  scored	  by	  Ki-­‐67	  immunohistochemistry	  was	  
examined	  and	  no	  difference	  was	  found.	  	  Also,	  differentiation	  of	  goblet	  cells	  as	  
examined	  by	  alcian	  blue	  staining	  yielded	  no	  difference	  between	  the	  two	  genotypes.	  	  
However,	  crypt	  fission	  was	  found	  to	  be	  elevated	  while	  crypt	  protrusion	  growth	  was	  
found	  to	  decrease.	  	  And,	  apoptosis	  was	  found	  to	  be	  decreased.	  	  In	  the	  large	  intestine,	  
proliferation,	  as	  scored	  by	  Ki-­‐67,	  was	  found	  to	  decrease.	  	  Crypt	  fission	  was	  found	  to	  
be	  decreased	  and	  no	  effect	  on	  apoptosis	  was	  observed.	  	  Together,	  these	  results	  
illustrate	  that	  the	  double-­‐negative	  feedback	  regulation	  between	  Apc	  and	  Msi1	  may	  
be	  more	  prominent	  in	  the	  small	  intestine	  and	  loss	  of	  Msi1	  in	  the	  colon	  may	  be	  
affecting	  more	  than	  just	  this	  particular	  regulatory	  mechanism.	  	  
	  
Summary	  
Colorectal	  cancer	  is	  a	  significant	  disease	  with	  a	  large	  impact	  on	  the	  U.S.	  population.	  	  
Colorectal	  cancer	  results	  from	  multiple	  mutations	  in	  tumor	  suppressors	  and	  
oncogenes	  that	  lead	  to	  the	  loss	  of	  homeostasis	  in	  the	  intestinal	  epithelium,	  
disrupting	  the	  natural	  process	  of	  proliferation,	  differentiation,	  and	  apoptosis.	  	  These	  
mutations	  are	  proposed	  to	  arise	  in	  the	  stem	  cells	  that	  govern	  cell	  turnover	  in	  the	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intestine	  because	  these	  cells	  have	  a	  long	  life	  span,	  which	  would	  allow	  for	  
accumulation	  of	  mutations.	  	  Msi1,	  a	  purported	  marker	  of	  stem	  cells,	  allows	  cells	  to	  
remain	  in	  an	  undifferentiated	  and	  proliferative	  state	  through	  its	  inhibition	  of	  
inhibitors	  of	  cell	  cycle	  progression	  and	  Notch	  signaling.	  	  Msi1	  was	  also	  shown	  to	  
regulate	  APC	  via	  inhibition	  of	  its	  translation.	  	  APC	  is	  mutated	  in	  80%	  of	  all	  CRCs	  as	  
the	  initiating	  step	  in	  tumorigenesis.	  	  APC	  mutation	  allows	  for	  uncontrolled	  Wnt	  
signaling	  in	  the	  intestine.	  	  Msi1,	  a	  Wnt	  target,	  is	  thereby	  influenced	  by	  APC	  mutation	  
and	  is	  therefore	  produced	  at	  higher	  levels.	  	  This	  disruption	  of	  regulation	  between	  
APC	  and	  Msi1	  would	  allow	  for	  uncontrolled	  levels	  of	  Msi1	  protein	  and	  thereby	  a	  
mechanism	  for	  cells	  to	  remain	  in	  a	  stem-­‐like	  state.	  	  Msi1	  could	  thereby	  be	  an	  








































Figure	  1.1.	  	  Intestinal	  Homeostasis.	  Cells	  in	  both	  the	  large	  and	  small	  intestine	  migrate	  from	  the	  
base	  of	  the	  crypt	  where	  stem	  cell	  populations	  exist,	  towards	  the	  lumen	  of	  the	  intestine	  where	  they	  
undergo	  apoptosis	  and	  are	  shed	  in	  a	  few	  days.	  	  As	  they	  move	  upwards	  and	  leave	  the	  proliferative	  
progenitor	  compartment,	  they	  differentiate	  into	  goblet,	  enteroendocrine,	  and	  enteroendocrine	  
cells,	  or	  their	  respective	  counterparts	  in	  the	  colon.	  Paneth	  cells,	  a	  fourth	  type	  of	  differentiated	  cell	  
in	  the	  small	  intestine,	  moves	  to	  the	  crypt	  base.	  Adapted	  from	  Medema,	  J.	  P.	  and	  Vermeulen,	  L.	  
(2011).	  Nature,	  474	  (7351),	  318-­26.	  	  
	  
	  






































Figure	  1.2.	  	  Wnt	  signaling	  in	  the	  intestine.	  	  In	  the	  left	  panel,	  when	  the	  Wnt	  signal	  is	  absent,	  the	  
destruction	  complex	  composed	  of	  APC,	  Axin,	  and	  Gsk-­3β	  will	  bind	  β-­catenin	  and	  Gsk-­3β	  will	  
phosphorylate	  it.	  	  	  Phosphorylation	  of	  	  β-­catenin	  leads	  to	  recruitment	  of	  βTrCP	  (not	  pictured)	  which	  
ubitquitinates	  	  β-­catenin	  leading	  to	  	  proteosomal	  degradation.	  	  In	  the	  right	  panel,	  when	  the	  Wnt	  signal	  
is	  present,	  the	  destruction	  complex	  is	  inhibited	  by	  mechanisms	  unknown	  and	  β-­catenin	  	  translocates	  
into	  the	  nucleus.	  β-­catenin	  will	  then	  bind	  TCF/LEF-­1	  transcription	  factors,	  which	  will	  allow	  for	  
transcription	  of	  Wnt	  target	  genes.	  	  
	  














Figure	  1.3.	  	  Domains	  of	  APC.	  	  APC	  is	  a	  multi-­domain	  protein	  with	  many	  cellular	  functions.	  	  Depicted	  here	  is	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Contribution	  of	  the	  Apc/Msi1	  Double-­Negative	  Feedback	  Loop	  to	  
Intestinal	  Cell	  Homeostasis	  in	  Mice	  




Colorectal	  cancer	  is	  proposed	  to	  arise	  due	  to	  misregulation	  of	  stem	  cells	  in	  
the	  intestinal	  epithelium.	  Adenomatous	  Polyposis	  Coli	  (APC)	  truncating	  mutations	  
have	  been	  implicated	  as	  the	  initiating	  event	  in	  80%	  of	  colorectal	  cancers.	  Musashi1	  
(MSI1),	  a	  translational	  inhibitor,	  has	  been	  found	  to	  be	  important	  in	  stem	  cell	  
regulation.	  	  Previously,	  the	  Neufeld	  lab	  identified	  a	  double-­‐negative	  feedback	  loop	  
between	  APC	  and	  MSI1,	  in	  vitro,	  using	  human	  colon	  cell	  lines.	  APC	  regulates	  MSI1	  
via	  Wnt	  signaling	  and	  MSI1	  targets	  APC	  mRNA	  for	  translational	  inhibition.	  	  Though	  
both	  APC	  and	  MSI1	  have	  been	  found	  to	  be	  important	  in	  tumorigenesis,	  the	  
implication	  of	  this	  double-­‐negative	  feedback	  loop	  on	  stem	  cell	  regulation	  and	  
tumorigenesis	  is	  unknown.	  	  We	  hypothesize	  that	  this	  double-­‐negative	  feedback	  loop	  
is	  key	  to	  maintaining	  balance	  between	  proliferation	  and	  differentiation	  in	  vivo.	  To	  
address	  the	  role	  of	  the	  APC/MSI1	  double-­‐negative	  feedback	  loop	  in	  vivo,	  we	  are	  
characterizing	  Msi1	  knockout	  mice	  for	  phenotypes	  associated	  with	  disruption	  of	  
this	  feedback	  loop	  in	  both	  the	  small	  intestine	  and	  colon.	  	  When	  comparing	  the	  small	  
intestine	  of	  Msi1	  knockout	  mice	  to	  wild-­‐type	  mice,	  we	  found	  down-­‐regulation	  of	  
Wnt	  target	  gene	  transcripts	  and	  lower	  Apc	  protein	  levels.	  	  Proliferation	  remained	  
unchanged	  as	  did	  goblet	  cell	  differentiation.	  	  An	  ex	  vivo	  culture	  system	  produced	  less	  
crypt-­‐like	  protrusions	  from	  Msi1-­‐/-­‐	  organoids.	  	  	  Apoptosis	  appeared	  to	  be	  reduced	  in	  
Msi1-­‐/-­‐	  small	  intestinal	  epithelia.	  	  	  When	  comparing	  the	  colons	  of	  Msi1	  knockout	  
mice	  and	  wild-­‐type	  mice,	  Wnt	  target	  gene	  	  expression	  was	  unaltered	  as	  were	  Apc	  
protein	  levels.	  	  However,	  proliferation	  was	  reduced	  in	  Msi1-­‐/-­‐	  colons	  as	  was	  crypt	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fission.	  	  Apoptosis	  was	  unaffected.	  	  We	  propose	  that	  disregulation	  of	  the	  APC/MSI1	  
double-­‐negative	  feedback	  loop	  leads	  to	  disruption	  of	  homeostasis	  in	  the	  small	  
intestine	  whereas	  in	  the	  colon	  it	  may	  not	  play	  an	  integral	  role.	  	  
	  
Introduction	  
	   	  
The	  intestinal	  system	  is	  one	  of	  the	  most	  rapidly	  renewing	  tissues	  in	  the	  body	  
and	  thus	  needs	  many	  levels	  of	  regulation	  in	  order	  to	  maintain	  homeostasis.	  	  The	  
intestine	  is	  composed	  of	  two	  stem	  cell	  populations	  that	  reside	  near	  the	  base	  of	  the	  
crypt	  and	  that	  undergo	  asymmetric	  division	  to	  give	  rise	  to	  all	  differentiated	  cells	  of	  
the	  intestine.	  “Active”	  (Lgr5-­‐positive)	  stem	  cells	  are	  located	  at	  the	  crypt	  base,	  
whereas	  “quiescent”	  (Bmi1-­‐positive)	  stem	  cells	  reside	  in	  the	  +4	  position	  above	  the	  
crypt	  bottom	  (Figure	  1.1).	  The	  daughter	  cells	  produced	  through	  asymmetric	  
division	  travel	  upward	  from	  the	  crypt	  base	  and	  upon	  reaching	  the	  crypt-­‐villus	  
junction	  further	  differentiate	  into	  the	  secretory	  or	  absorptive	  cells.	  	  Paneth	  cells	  are	  
the	  only	  differentiated	  cell	  type	  to	  move	  to	  the	  crypt	  bottom,	  where	  they	  help	  to	  
maintain	  the	  stem	  cell	  niche	  (1).	  	  	  Misregulation	  of	  intestinal	  homeostasis	  via	  
mutation	  of	  either	  stem	  cell	  population	  has	  been	  shown	  to	  initiate	  adenoma	  
formation,	  which	  may	  eventually	  progress	  to	  colorectal	  cancer	  (2,	  3).	  	  	  
Mutation	  of	  APC	  is	  the	  initiating	  event	  in	  ~80%	  of	  all	  sporadic	  colorectal	  
cancers	  and	  germ-­‐line	  APC	  mutations	  are	  associate	  with	  the	  syndrome	  familial	  
adenomatous	  Polyposis	  (FAP).	  	  Persons	  with	  FAP	  have	  hundreds	  to	  thousands	  of	  
colonic	  polyps	  by	  early	  adolescence	  and	  colon	  cancer	  by	  middle	  age	  if	  their	  colon	  is	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not	  removed.	  	  A	  role	  for	  APC	  in	  tumorigenesis	  is	  linked	  to	  its	  function	  as	  a	  negative	  
regulator	  of	  the	  canonical	  Wnt	  pathway	  where	  APC	  acts	  as	  a	  scaffold	  protein	  in	  a	  
destruction	  complex	  that	  targets	  transcription	  factor	  β-­‐catenin	  for	  proteasomal	  
degradation.	  	  Wnt	  signaling	  is	  important	  to	  maintain	  the	  stem	  cell	  niche	  in	  the	  
intestine;	  secreted	  Wnt	  signal	  allows	  progenitors	  to	  maintain	  a	  proliferative	  stem-­‐
like	  state.	  Conditional	  	  loss	  of	  Apc	  in	  adult	  mice	  leads	  to	  increased	  size	  of	  the	  
progenitor	  compartment,	  more	  proliferative	  cells	  and	  more	  undifferentiated	  cells.	  	  
These	  mice	  also	  had	  increased	  expression	  of	  the	  RNA-­‐binding	  protein	  Musashi1	  
(Msi1)	  (4).	  	  	  
Msi1	  has	  previously	  been	  shown	  to	  be	  a	  stem	  cell	  marker	  in	  the	  intestine	  (5)	  
and	  has	  also	  been	  linked	  to	  maintaining	  cells	  in	  a	  progenitor	  state.	  	  Msi1	  is	  known	  
for	  its	  role	  as	  a	  translational	  inhibitor	  of	  m-­numb,	  an	  inhibitor	  of	  the	  Notch	  pathway,	  
which	  allows	  for	  activation	  of	  Notch	  and	  maintenance	  of	  cells	  in	  a	  non-­‐differentiated	  
state	  (6).	  Msi1	  has	  also	  been	  shown	  to	  be	  an	  inhibitor	  of	  p21WAF-­‐1	  allowing	  neural	  
cells	  to	  be	  maintained	  in	  an	  actively	  cycling	  state	  (7).	  Ultimately,	  both	  Msi1	  and	  APC	  
participate	  in	  the	  balance	  of	  proliferation	  versus	  differentiation	  in	  the	  intestine.	  	  
Previous	  work	  in	  our	  lab	  showed	  a	  negative	  feedback	  loop	  between	  APC	  and	  
Msi1	  in	  cultured	  cells.	  	  APC	  is	  an	  inhibitor	  of	  MSI1	  (8)	  and	  this	  inhibition	  involved	  
the	  Wnt	  pathway	  (9).	  	  MSI1,	  in	  turn,	  inhibits	  translation	  of	  APC	  (8).	  To	  date,	  the	  
studies	  supporting	  a	  double-­‐negative	  feedback	  loop	  between	  APC	  and	  MSI1	  were	  
performed	  in	  cultured	  cells.	  	  Therefore,	  it	  is	  unknown	  how	  this	  double-­‐negative	  
feedback	  loop	  affects	  the	  homeostasis	  of	  intestinal	  tissue	  or	  whether	  disruption	  of	  
this	  feedback	  loop	  disrupts	  the	  balance	  between	  proliferation	  and	  differentiation	  in	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the	  intestine.	  To	  investigate	  this	  feedback	  loop	  in	  vivo,	  we	  utilized	  Msi1-­‐/-­‐	  	  mice	  to	  
examine	  phenotypes	  related	  to	  disruption	  of	  this	  feedback	  loop	  and	  the	  effects	  on	  
Wnt	  signaling	  	  in	  both	  the	  small	  intestine	  and	  the	  colon.	  	  These	  mice	  were	  generated	  
in	  the	  Okano	  lab	  by	  using	  a	  targeting	  construct	  to	  delete	  the	  entire	  Msi	  gene.	  	  Msi	  
knockout	  in	  these	  mice	  lead	  to	  abnormal	  brain	  development	  but	  are	  not	  lethal	  (10).	  	  
However,	  phenotypes	  in	  the	  intestine	  caused	  by	  Msi	  knockout	  have	  not	  been	  
examined.	  	  We	  hypothesized	  that	  in	  this	  model,	  Msi1	  deletion	  would	  lead	  to	  
increased	  levels	  of	  Apc,	  causing	  a	  subsequent	  decrease	  in	  Wnt	  signaling.	  	  In	  the	  
current	  study,	  we	  demonstrate	  that	  the	  small	  intestine	  and	  colon	  display	  distinct	  
phenotypes	  in	  mice	  with	  Msi1	  deletions.	  	  In	  the	  small	  intestine,	  Apc	  protein	  levels	  in	  
Msi1-­‐/-­‐	  	  mice	  were	  slightly	  elevated	  	  Wnt	  target	  genes	  were	  downregulated.	  	  
Proliferation	  was	  unaffected,	  though	  crypt	  fission	  was	  decreased.	  	  Goblet	  cell	  
differentiation	  was	  unaffected	  and	  apoptosis	  was	  decreased.	  	  In	  the	  colon,	  no	  change	  
was	  seen	  in	  Apc	  protein	  expression	  or	  Wnt	  target	  gene	  expression.	  	  Proliferation	  
was	  found	  to	  decrease	  though	  crypt	  fission	  was	  found	  to	  increase.	  	  Apoptosis	  was	  
unaffected.	  	  These	  results	  suggest	  that	  the	  Msi1/Apc	  negative	  feedback	  loop	  in	  the	  
small	  intestine	  of	  mice	  plays	  a	  role	  in	  intestinal	  homeostasis	  while	  Msi1	  loss	  in	  the	  
colon	  	  leads	  to	  phenotypes	  not	  related	  to	  Wnt	  signaling.	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ICR129	  Msi1-­‐/-­‐mice	  in	  CD-­‐1	  background	  were	  a	  kind	  gift	  from	  the	  Okano	  lab	  and	  
were	  used	  for	  this	  study.	  	  Briefly,	  Msi1-­‐/-­‐	  mice	  	  were	  generated	  by	  replacing	  4	  exons	  
of	  the	  msi1	  gene,	  including	  the	  initiation	  codon,	  with	  a	  Neo	  cassette	  through	  
homologous	  recombination.	  	  Msi1	  knockout	  was	  confirmed	  by	  Western	  blot	  (10).	  	  
Apc1322T	  mice	  from	  Ian	  Tomlinson	  in	  C57BL6	  background.	  
	  
Mouse	  Genotyping	  
After	  weaning,	  mice	  were	  identified	  with	  a	  metal	  ear	  tag.	  	  In	  order	  to	  determine	  
genotype,	  tail	  DNA	  was	  isolated	  from	  the	  mice	  and	  the	  PCR	  protocol	  from	  Riken	  BRC	  	  
PCR	  protocol	  RBRC04435	  was	  used.	  Primer	  sets	  used	  to	  genotype	  mice	  for	  Msi1	  
knockout	  allele	  (5’-­‐CTGAGCTATCTCCAACCCGACCCAG-­‐3’	  and	  5’-­‐
TCCAGACTGCCTTGGGAAAAAGCGCCT-­‐3’;	  280	  bp)	  and	  wild-­‐type	  allele	  (5’-­‐
TGAAAGAGTGTCTGGTGATGCGGGAC-­‐3’	  and	  5’-­‐TTGGAGTCGAGCTCGTGCCGCGATT-­‐
3’).	  	  Two	  separate	  reactions	  were	  run	  simultaneously	  for	  each	  mouse	  including	  the	  
Msi1	  knockout	  primers	  and	  wild-­‐type	  primers.	  	  Reaction	  conditions	  were	  as	  follows:	  	  
94°C	  for	  3	  minutes,	  94°C	  for	  30	  seconds,	  60°C	  for	  30	  seconds,	  72°C	  for	  1	  minute,	  and	  
72°C	  for	  5	  minutes.	  
	  
Isolation	  of	  mouse	  intestinal	  epithelial	  cells	  
Small	  Intestine,	  from	  below	  the	  stomach	  to	  the	  cecum,	  and	  colon,	  including	  cecum,	  
was	  removed	  from	  10-­‐11	  week	  old	  mice.	  	  In	  order	  to	  isolate	  intestinal	  epithelia	  cells,	  
small	  intestine	  and	  colon	  were	  opened	  longitudinally.	  	  Each	  intestinal	  piece	  was	  
placed	  into	  a	  50	  mL	  conical	  tube	  containing	  cell	  isolation	  buffer	  (3	  mM	  EDTA,	  0.5mM	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dithiothreitol	  (DTT))	  and	  incubated	  for	  90	  minutes	  room	  at	  temperature.	  	  Intestinal	  
pieces	  were	  removed	  from	  cell	  isolation	  buffer,	  and	  placed	  into	  15	  mL	  conicals	  
containing	  12	  mL	  of	  PBS	  and	  shaken	  vigorously	  for	  20	  seconds	  to	  release	  epithelial	  
cells.	  	  Intestinal	  pieces	  were	  removed	  from	  tubes	  prior	  to	  centrifugation	  at	  700	  g	  for	  
5	  min	  to	  pellet	  cells.	  	  Crypt	  supernatants	  were	  removed	  and	  pellets	  were	  
resuspended	  in	  5	  mL	  PBS	  for	  the	  small	  intestine	  and	  2.5	  mL	  PBS	  for	  the	  colon.	  	  One	  
ml	  and	  300	  µL	  aliquots	  of	  each	  cell	  suspension	  were	  placed	  into	  fresh	  microfuge	  
tubes	  and	  centrifuged	  at	  15,800	  g	  and	  supernatant	  was	  removed.	  	  The	  pellet	  from	  
the	  1	  mL	  aliquot	  was	  resuspended	  in	  1	  mL	  of	  Trizol	  (Invitrogen)	  and	  stored	  at	  -­‐80°C	  
to	  be	  used	  for	  RNA	  analysis.	  	  The	  pellet	  from	  the	  300	  µL	  aliquot	  was	  resuspended	  in	  
5x	  sample	  buffer	  (25%	  glycerol,	  3.12	  mM	  Tris-­‐HCL	  pH=6.8,	  10%	  w/v	  sodium	  
dodecyl	  sulfate,	  0.0027%	  bromphenol	  blue	  in	  ethanol	  for	  color,	  5%	  2-­‐
mercaptoethanol)	  and	  heated	  at	  100°C	  for	  2	  min,	  vortexed,	  heated	  again	  at	  100°C	  
for	  2	  min	  and	  stored	  at	  -­‐80°C	  to	  be	  used	  for	  immunoblot	  analysis.	  	  
	  
Immunohistochemistry	  of	  intestinal	  epithelia	  
	  
Jejunums	  from	  the	  small	  intestine	  and	  the	  whole	  colon	  excluding	  the	  cecum	  were	  
isolated	  from	  13	  week	  old	  mice	  of	  each	  genotype.	  Tissue	  was	  fixed	  in	  10%	  saline-­‐
buffered	  formalin	  overnight	  (less	  than	  24	  hours)	  at	  4°C	  and	  then	  stored	  in	  70%	  
ethanol	  for	  24	  hours	  at	  4°C.	  	  Tissues	  were	  embedded	  in	  paraffin	  and	  sectioned	  at	  8	  
µm.	  	  Immunohistochemistry	  for	  Ki-­‐67	  was	  performed	  using	  the	  histomouse	  kit	  
(Invitrogen	  cat.	  No.	  95-­‐9541)	  according	  to	  the	  manufacturer’s	  protocol	  	  and	  were	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incubated	  with	  rat	  anti-­‐mouse	  Ki-­‐67	  antibody	  (1:20	  Dako	  cat.	  No.	  M7249)	  overnight.	  	  
Sections	  were	  counterstained	  with	  hematoxylin	  and	  coded	  for	  blind	  scoring.	  	  48-­‐50	  
crypts	  75-­‐145	  µm	  in	  length	  in	  the	  jejunum	  tissue	  samples	  and	  27-­‐100	  crypts	  75-­‐145	  
µm	  in	  length	  in	  the	  colon	  samples	  were	  scored	  for	  Ki-­‐67-­‐postive	  cells	  using	  the	  20x	  
objective	  and	  a	  Zeiss	  Axiovert	  135	  microscope.	  The	  average	  of	  all	  samples/crypt	  
were	  evaluated	  for	  significance	  using	  unpaired,	  two-­‐tailed	  t-­‐tests	  calculated	  by	  
Microsoft	  Excel.	  	  Representative	  images	  of	  crypts	  were	  captured	  using	  the	  40x	  
objective	  on	  Nikon	  Eclipse	  80i	  microscope	  with	  Optronics	  Magnafire	  SP	  digital	  
camera	  and	  acquired	  with	  Magnafire	  software.	  	  
	  
Scoring	  goblet	  cells.	  
	  
Jejunum	  was	  isolated	  from	  4	  mice	  of	  each	  genotype	  at	  12	  weeks	  of	  age.	  Processing	  of	  
tissue	  was	  performed	  as	  in	  immunohistochemistry	  of	  intestinal	  epithelia.	  A	  protocol	  
adapted	  from	  IHCworld.com	  for	  alcian	  blue	  staining	  was	  followed.	  	  Tissue	  was	  
deparafinized	  and	  rehydrated	  in	  an	  ethanol	  series	  followed	  by	  staining	  with	  alcian	  
blue	  for	  30	  minutes	  to	  stain	  goblet	  cells.	  	  Tissue	  was	  then	  dehydrated	  through	  an	  
ethanol	  series	  and	  xylene	  washing	  and	  mounted	  with	  xylene	  mounting	  medium	  and	  
coded	  for	  blind	  scoring.	  	  Images	  of	  representative	  jejunum	  were	  captured	  with	  the	  
10x	  objective	  on	  Nikon	  Eclipse	  80i	  microscope	  with	  Optronics	  Magnafire	  SP	  digital	  
camera	  and	  acquired	  with	  Magnafire	  software.	  The	  bottom	  183	  µm	  of	  each	  villi	  was	  
scored	  	  for	  26-­‐58	  villi	  per	  Msi1+/+	  and	  21-­‐68	  villi	  per	  Msi1-­‐/-­‐	  mouse.	  The	  average	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number	  of	  alcian	  blue-­‐positive	  cells	  was	  calculated	  for	  each	  mouse	  and	  evaluated	  for	  




Protein	  samples	  were	  separated	  by	  polyacrylamide	  gel	  electrophoresis	  and	  
transferred	  to	  a	  nitrocellulose	  membrane.	  	  Blots	  were	  blocked	  with	  5%	  non-­‐fat	  dry	  
milk/TBST	  and	  probed	  in	  this	  solution	  as	  well.	  Blots	  were	  probed	  with	  the	  following	  
primary	  antibodies:	  rabbit	  anti-­‐APC	  M2	  1:3000	  (11),	  mouse	  anti	  β-­‐actin	  1:3000	  
(Sigma),	  and	  rabbit	  anti-­‐histone	  H2A.x	  1:3000(Abcam	  #ab11175).	  	  Secondary	  
antibodies	  used	  included:	  horseradish	  peroxidase	  goat	  anti-­‐rabbit	  IgG	  (Bio-­‐Rad	  cat.	  
No.	  172-­‐1019)	  and	  HRP-­‐rabbit	  anti-­‐mouse	  IgGγ	  (Zymed	  cat.	  no.	  61-­‐6020).	  	  Blots	  
were	  developed	  using	  SuperSignal	  West	  Femto	  Maximum	  Sensitivity	  Substrate	  
(Pierce)	  and	  a	  Kodak	  Image	  Station	  4000R.	  	  Band	  intensity	  was	  analyzed	  using	  
Kodak	  ID	  Image	  Analysis	  Software	  and	  sum	  integer	  values	  were	  used.	  	  Apc	  protein	  
band	  intensity	  was	  first	  normalized	  to	  β-­‐actin	  and	  values	  for	  Msi1+/+	  were	  set	  to	  1.	  
When	  evaluating	  apoptosis,	  β-­‐fractin	  band	  intensity	  was	  normalized	  to	  histone	  
H2A.x.	  Values	  for	  Msi1+/+	  were	  set	  to	  1	  in	  all	  experiments.	  	  The	  p-­‐values	  were	  
calculated	  by	  two-­‐tailed	  Mann-­‐Whitney	  non-­‐parametric	  test.	  
	  
Crypt	  fission	  analysis	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For	  small	  intestine:	  the	  distal	  1	  cm	  of	  tissue	  was	  removed,	  opened	  longitudinally	  
and	  incubated	  in	  30mM	  EDTA	  in	  PBS	  solution	  on	  ice	  for	  20	  min.	  	  The	  intestine	  was	  
washed	  once	  in	  PBS,	  added	  to	  25	  mL	  of	  PBS,	  and	  shaken	  for	  5	  min	  at	  3	  
shakes/second	  to	  dissociate	  crypts	  and	  villi.	  	  The	  intestinal	  piece	  was	  removed	  and	  
the	  solution	  was	  filtered	  through	  a	  70	  µm	  filter	  to	  remove	  villi.	  	  An	  aliquot	  of	  100	  µL	  
was	  removed	  and	  scored	  using	  light	  microscopy	  with	  the	  16x	  objective	  on	  a	  Zeiss	  
Axiovert	  135	  microscope.	  	  Representative	  images	  were	  taken	  on	  the	  same	  
microscope	  with	  the	  Hamamatsu	  digital	  camera	  610600	  ORCA-­‐R2	  and	  acquired	  with	  
HCImage	  Live	  V3.0	  software.	  	  Crypts	  undergoing	  fission	  were	  scored	  as	  a	  percent	  of	  
the	  total	  crypts	  counted/mouse	  and	  the	  data	  from	  each	  mouse	  of	  a	  given	  genotype	  
were	  averaged.	  The	  p-­‐values	  were	  calculated	  by	  two-­‐tailed	  Mann-­‐Whitney	  non-­‐
parametric	  test.	  
	  
For	  colon:	  the	  distal	  1	  cm	  	  of	  colon	  was	  removed,	  opened	  longitudinally,	  and	  
incubated	  in	  30	  mM	  EDTA	  solution	  in	  PBS	  on	  ice	  for	  20	  min.	  	  The	  colon	  piece	  was	  
removed	  from	  EDTA	  solution,	  placed	  into	  500	  µL	  of	  PBS,	  and	  shaken	  vigorously	  for	  
5	  minutes.	  	  A	  100	  µL	  aliquot	  was	  removed	  scored	  as	  for	  the	  small	  intestine	  using	  the	  
same	  microscope	  and	  camera	  for	  pictures	  and	  data	  collection.	  
	  
Crypt	  Organoid	  Culture	  system	  
	  
One	  mouse	  of	  each	  genotype	  was	  culled	  at	  5	  weeks	  of	  age	  and	  the	  small	  intestine	  
removed.	  	  The	  small	  intestine	  was	  opened	  longitudinally,	  washed	  3x	  with	  cold	  HBSS	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(Calcium	  and	  magnesium	  free)	  and	  cut	  into	  ~	  1	  cm	  pieces.	  	  The	  pieces	  were	  placed	  
into	  30	  mM	  EDTA/PBS	  and	  allowed	  to	  incubate	  on	  ice	  for	  20	  min.	  	  EDTA	  solution	  
was	  removed	  and	  tissue	  was	  washed	  with	  50	  mL	  of	  	  cold	  HBSS.	  After	  the	  HBSS	  
wash,25	  mL	  of	  cold	  HBSS	  was	  added	  to	  the	  tissue.	  	  Intestinal	  pieces	  were	  shaken	  for	  
5	  min	  at	  3	  shakes/second	  to	  dissociate	  crypts	  and	  villi.	  	  Solution	  containing	  crypts	  
and	  villi	  was	  poured	  through	  a	  70	  µm	  filter	  to	  remove	  villi.	  	  The	  solution	  was	  then	  
centrifuged	  at	  250	  g	  for	  5	  min	  to	  pellet	  crypts	  and	  supernatant	  was	  removed.	  	  Crypt	  
pellets	  were	  resuspended	  in	  25	  mL	  of	  basal	  media	  including:	  advanced	  DMEM-­‐F12	  
(Gibco	  cat.	  no.	  12634-­‐010),	  200	  mM	  L-­‐glutamine,	  10	  mM	  Hepes	  pH	  7.5.	  	  Crypt	  
solutions	  were	  centrifuged	  at	  200	  g	  and	  most	  of	  supernatant	  was	  removed	  leaving	  2	  
mL	  in	  which	  crypt	  pellet	  was	  resuspended.	  	  Using	  wide-­‐bore	  pipettes	  40	  µL	  of	  crypt	  
solution	  was	  added	  to	  40	  µL	  of	  basal	  media	  in	  5%	  BSA	  coated-­‐microfuge	  tubes	  
(crypts	  diluted	  1:2).	  	  80	  µL	  of	  matrigel	  (BD	  matrigel	  basement	  membrane	  matrix	  
growth	  factor	  reduced,	  cat.	  no.	  354230)	  was	  added	  to	  crypt	  solution	  
(crypts:matrigel	  =	  1:1).	  	  40	  µL	  of	  crypt-­‐matrigel	  solution	  was	  plated	  directly	  to	  the	  
center	  of	  	  the	  well	  (without	  allowing	  solution	  to	  touch	  sides	  of	  the	  well)	  in	  24	  well	  
plates	  and	  incubated	  for	  20	  min	  at	  37°C	  with	  5%	  carbon	  dioxide	  to	  allow	  matrigel	  to	  
solidify.	  Once	  solidified,	  400	  µL	  of	  overlay	  was	  added	  to	  each	  well	  and	  incubated	  at	  
37°C	  with	  5%	  carbon	  dioxide	  for	  the	  duration	  of	  the	  experiment.	  	  Overlay	  included:	  
100	  ng/mL	  Noggin	  (Peprotech	  cat.	  no.	  250-­‐38),	  10	  ng/mL	  of	  EGF	  (Peprotech	  cat.	  no.	  
PMG8044),	  500	  ng/mL	  R-­‐spondin1	  (Sino	  Biological	  cat.	  no.	  50316-­‐M08H),	  1	  x	  
Penicillin-­‐Streptomycin	  (Gibco	  cat.	  no.	  15140-­‐148)	  in	  basal	  media.	  	  	  Organoids	  
formed	  from	  plated	  crypts	  and	  protrusions	  were	  scored	  beginning	  one	  day	  (24	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hours)	  after	  plating	  using	  a	  dissecting	  scope	  to	  count	  the	  number	  of	  protrusions	  on	  
each	  organoid.	  	  For	  Msi1-­‐/-­‐	  and	  Msi1+/+	  cultures,	  all	  organoids	  were	  scored	  in	  all	  
wells	  for	  protrusions,	  10-­‐662	  organoids	  in	  Msi1-­‐/-­‐	  cultures	  and	  78-­‐495	  in	  Msi1+/+	  
cultures.	  	  In	  Apc1322T/+	  cultures,	  5	  non-­‐overlapping	  views	  were	  scored	  in	  each	  well	  
for	  organoids.	  	  In	  the	  Apc1322T/+	  culture,	  	  207-­‐802	  organoids	  were	  scored	  for	  
protrusions	  and	  in	  the	  Apc+/+311-­‐1061	  organoids	  were	  scored.	  	  The	  data	  	  for	  the	  
Msi1	  culture	  is	  presented	  as	  a	  box-­‐and-­‐whisker	  plot,	  while	  the	  data	  for	  the	  
Apc1322T/+	  culture	  is	  presented	  as	  the	  average	  protrusions/organoid.	  	  The	  cultures	  
were	  prepared	  from	  one	  mouse	  per	  genotype	  total.	  	  Significance	  was	  calculated	  
using	  a	  student	  t-­‐test.	  	  
	   In	  the	  Msi1	  crypt	  culture,	  organoids	  were	  passed	  on	  day	  9	  after	  initial	  
plating.	  	  Passaging	  was	  performed	  by	  removing	  crypts	  and	  media	  from	  3	  wells	  by	  
pipetting	  vigorously	  and	  scraping	  matrigel	  with	  pipette	  tip	  to	  dislodge	  from	  the	  well	  
bottom	  and	  combining	  crypt	  solutions	  into	  5%	  BSA-­‐coated	  microfuge	  tubes.	  	  Crypt	  
solutions	  were	  centrifuged	  at	  200	  g	  and	  pellets	  containing	  organoids	  were	  
resuspended	  in	  100	  µL	  of	  matrigel	  and	  40	  µL	  of	  suspension	  was	  added	  to	  each	  well	  
of	  a	  24	  well	  plate.	  	  	  Plates	  were	  then	  kept	  at	  37°C	  with	  5%	  carbon	  dioxide	  to	  allow	  
matrigel	  to	  solidify	  for	  20	  min.	  	  400	  µL	  of	  overlay	  was	  added	  to	  crypts	  and	  crypts	  
were	  scored	  each	  day	  for	  protrusions	  until	  organoid	  number	  fell	  below	  10	  
organoids	  in	  the	  Msi1-­‐/-­‐	  cultures.	  
	  
Analysis	  of	  mRNA	  by	  real-­time	  reverse	  transcription-­PCR	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RNA	  was	  prepared	  from	  intestinal	  epithelial	  cells	  isolated	  from	  Msi1+/+	  and	  Msi1-­‐/-­‐	  
mice	  as	  described	  in	  the	  section	  Isolation	  of	  mouse	  intestinal	  epithelial	  cells	  and	  rt-­‐
PCR	  was	  performed	  to	  analyze	  Wnt	  target	  genes	  as	  described	  	  in	  (12).	  
	  	  
Results	  in	  the	  small	  intestine	  
	  
APC	  protein	  levels	  increased	  in	  Msi1-­/-­	  mice.	  	  	  
	  
	   To	  investigate	  whether	  the	  APC/MSI1	  double-­‐negative	  feedback	  loop	  was	  
maintained	  in	  the	  small	  intestine,	  we	  used	  Msi1-­‐/-­‐	  mice	  generated	  in	  the	  Okano	  lab,	  
which	  have	  a	  germ-­‐line	  deletion	  of	  Msi1(10).	  	  	  We	  hypothesized	  that	  in	  this	  model,	  
Apc	  levels	  would	  increase	  due	  to	  an	  alleviation	  of	  translational	  repression	  mediated	  
by	  Msi1.	  	  To	  test	  this	  hypothesis,	  we	  isolated	  protein	  from	  small	  intestinal	  epithelial	  
cells	  and	  examined	  Apc	  protein	  levels	  via	  immunoblot.	  	  Apc	  protein	  levels	  in	  Msi1-­‐/-­‐	  
mice	  increased	  with	  respect	  to	  Msi1+/+	  mice,	  though	  not	  significantly	  (Fig.	  2.1A	  and	  
2.1B).	  	  This	  result	  suggests	  that	  the	  absence	  of	  Msi1	  does	  significantly	  affect	  Apc	  
protein	  levels	  when	  combining	  the	  entire	  small	  intestinal	  epithelia.	  	  However,	  the	  
slight	  increase	  in	  this	  total	  Apc	  level	  leaves	  open	  the	  possibility	  that	  the	  Apc/Msi1	  
double-­‐negative	  feedback	  loop	  is	  maintained	  in	  only	  a	  subset	  of	  small	  intestinal	  
cells.	  
	  
Wnt	  target	  gene	  expression	  is	  down-­regulated	  in	  Msi1-­/-­	  	  mice.	  
	  
	   36	  
Because	  a	  slight	  elevation	  in	  Apc	  level	  was	  seen	  in	  the	  small	  intestine	  of	  Msi1-­‐
/-­‐	  mice,	  we	  examined	  the	  effect	  of	  disrupting	  Apc/Msi1	  double-­‐negative	  feedback	  
regulation	  on	  Wnt	  target	  genes.	  	  Apc	  is	  a	  negative	  regulator	  of	  Wnt	  signaling	  and	  
therefore,	  was	  expected	  to	  have	  an	  inhibitory	  effect	  on	  the	  expression	  of	  Wnt	  target	  
genes.	  	  To	  evaluate	  Wnt	  target	  gene	  expression,	  we	  isolated	  mRNA	  from	  intestinal	  
epithelial	  cells	  and	  quantified	  the	  relative	  expression	  of	  four	  canonical	  Wnt	  target	  
genes	  (Figure	  2.2).	  Three	  genes	  upregulated	  by	  the	  canonical	  Wnt	  pathway,	  c-­Myc	  ,	  
axin-­2,	  and	  cyclin-­D1,	  showed	  lower	  expression	  in	  Msi1-­‐/-­‐	  	  mice	  than	  in	  Msi1+/+	  mice.	  	  
BTEB2,	  a	  gene	  regulated	  by	  non-­‐canonical	  Wnt	  signaling,	  showed	  no	  change	  in	  
expression.	  	  Unexpectedly,	  Hath-­1,	  a	  gene	  down-­‐regulated	  by	  canonical	  Wnt	  
signaling	  showed	  no	  significant	  alteration	  in	  expression	  levels	  between	  Msi1-­‐/-­‐	  and	  
Msi1+/+	  mice.	  
	  
No	  significant	  change	  in	  proliferation	  in	  intestinal	  epithelia	  of	  Msi1-­/-­	  mice.	  
	  
Due	  to	  decreased	  Wnt	  signaling,	  we	  expected	  to	  see	  a	  subsequent	  decrease	  in	  
proliferation	  in	  the	  small	  intestine.	  	  In	  order	  to	  examine	  proliferation,	  
immunohistochemistry	  was	  performed	  on	  paraffin-­‐embedded	  jejunum	  from	  mice	  
using	  Ki67	  as	  a	  proliferation	  marker.	  	  Unexpectedly,	  crypts	  showed	  no	  significant	  
change	  in	  proliferating	  cells/crypt	  between	  Msi1-­‐/-­‐	  and	  Msi1+/+	  mice	  (Figure	  2.3).	  
	  
No	  significant	  change	  in	  Goblet	  cell	  differentiation	  in	  small	  intestine	  of	  Msi1-­/-­	  mice.	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Inhibition	  of	  the	  Wnt	  signaling	  pathway	  has	  been	  shown	  to	  ablate	  
differentiation	  of	  secretory	  cells	  in	  the	  small	  intestine	  such	  as	  goblet	  cells	  (13).	  	  
Because	  Wnt	  target	  genes	  were	  inhibited	  in	  Msi1-­‐/-­‐	  mice,	  we	  next	  examined	  the	  
effect	  of	  Msi1	  knockout	  on	  goblet	  cell	  differentiation	  in	  the	  small	  intestine.	  	  Jejunum	  
was	  isolated	  from	  the	  mice,	  paraffin	  embedded,	  and	  stained	  with	  alcian	  blue,	  a	  
marker	  for	  goblet	  cells.	  	  Unexpectedly,	  no	  significant	  change	  was	  detected	  in	  the	  
number	  of	  goblet	  cells	  in	  villi	  between	  Msi1-­‐/-­‐	  and	  Msi1+/+	  mice.	  
	  
Elevation	  of	  crypt	  fission	  in	  the	  small	  intestine	  of	  Msi1-­/-­	  mice.	  
	  
	   Crypt	  fission	  is	  a	  mechanism	  by	  which	  crypts	  are	  proposed	  to	  spread	  
throughout	  the	  intestine	  in	  a	  short	  postnatal	  period.	  	  In	  mice,	  crypt	  doubling	  peaks	  
within	  the	  first	  three	  months	  of	  life.	  	  Crypts	  will	  then	  undergo	  fission	  only	  gradually	  
with	  age.	  	  Crypt	  fission	  is	  a	  proposed	  to	  result	  from	  an	  expansion	  of	  stem	  cell	  
populations	  that	  causes	  an	  increase	  in	  proliferating	  cells,	  resulting	  in	  a	  structurally	  
unstable	  crypt.	  	  When	  a	  threshold	  number	  of	  stem	  cells	  are	  exceeded	  in	  the	  crypt,	  
the	  crypt	  will	  undergo	  fission	  (14).	  A	  crypt	  undergoing	  fission	  will	  bifurcate	  at	  the	  
bottom	  and	  eventually	  produce	  two	  daughter	  crypts	  (Figure	  2.5A).	  	  Thus	  crypt	  
fission	  can	  be	  used	  as	  an	  epiphenomenon	  of	  	  stem	  cell	  number	  (14).	  	  	  
In	  Msi-­‐/-­‐	  mice,	  we	  predicted	  a	  decrease	  in	  crypt	  fission	  because	  Msi1	  has	  been	  
shown	  play	  an	  active	  role	  in	  maintaining	  stem	  cell	  division	  in	  neural	  cells	  (15).	  	  In	  
order	  to	  examine	  effects	  of	  Msi1	  knockout	  on	  stem	  cell	  populations	  in	  the	  intestine,	  
we	  looked	  at	  crypt	  fission	  in	  both	  mice	  populations	  by	  scoring	  isolated	  crypts	  for	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crypt	  fission	  (Figure	  2.5B).	  	  	  Unexpectedly,	  crypts	  in	  Msi1-­‐/-­‐	  mice	  had	  significant	  
elevation	  in	  crypt	  fission	  compared	  to	  Msi1+/+	  mice	  (Figure	  2.5C).	  	  	  
	  
Decrease	  in	  protrusions/organoid	  in	  Msi1-­/-­	  mice.	  
As	  a	  second	  method	  to	  determine	  crypt	  cell	  population	  differences	  in	  mice	  
of	  both	  genotypes,	  we	  used	  an	  ex	  vivo	  culture	  system	  of	  isolated	  small	  intestinal	  
crypts	  from	  the	  mice.	  	  In	  this	  system	  adapted	  from	  Sato	  et	  al.,	  2009	  and	  David	  
Sackville’s	  thesis,	  crypts	  are	  removed	  from	  surrounding	  mesenchymal	  tissue,	  
separated	  from	  villi,	  and	  plated	  in	  a	  laming-­‐rich	  3D	  media,	  matrigel.	  	  The	  crypts	  are	  
provided	  with	  external	  signals.	  R-­‐spondin1,	  a	  critical	  component	  of	  this	  external	  
signals	  mixture,	  enhances	  Wnt	  signaling	  allowing	  crypts	  to	  continue	  to	  proliferate	  
(16).	  	  Once	  the	  crypts	  are	  in	  culture,	  they	  produce	  organoid	  structures,	  with	  
differentiated	  secretory	  and	  absorptive	  cells	  present	  along	  the	  luminal	  surface	  of	  the	  
organoid.	  	  After	  24	  hours	  in	  culture,	  the	  organoids	  will	  produce	  new	  crypt-­‐like	  
protrusions	  from	  stem	  cells	  (refer	  to	  schematic,	  Figure	  2.6A)	  (17).	  	  Because	  
protrusions	  arise	  from	  stem	  cells,	  counting	  the	  number	  of	  protrusions	  per	  organoid	  
would	  be	  a	  way	  to	  determine	  general	  differences	  in	  stem	  cell	  populations.	  
To	  provide	  proof	  of	  concept	  that	  this	  ex	  vivo	  culture	  system	  could	  be	  used	  
to	  determine	  stem	  cell	  population	  differences,	  we	  first	  cultured	  crypts	  isolated	  from	  
an	  APC1322T/+	  mouse	  and	  a	  wild-­‐type	  mouse.	  	  A	  previous	  study	  using	  the	  APC1322T/+	  
mouse	  model	  showed	  that	  these	  mice	  have	  a	  higher	  Lgr5+	  stem	  cell	  population	  than	  
wild-­‐type	  mice	  (18).	  	  After	  culturing	  APC1322T/+	  organoids	  for	  five	  days,	  APC1322T/+	  
had	  significantly	  more	  protrusions	  than	  wild-­‐type	  organoids	  (2.6B).	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Because	  Msi1	  overexpression	  has	  been	  correlated	  to	  expansion	  of	  stem	  cell	  
populations	  (9),	  we	  expected	  that	  knockout	  of	  Msi1,	  in	  this	  culture	  system,	  would	  
produce	  organoids	  with	  fewer	  protrusions.	  	  In	  order	  to	  ascertain	  stem	  cell	  
population	  differences,	  we	  allowed	  crypts	  to	  grow	  in	  culture	  and	  counted	  
protrusions	  on	  each	  organoid.	  After	  8	  days	  of	  growth,	  crypts	  from	  Msi1-­‐/-­‐	  mice	  had	  
less	  protrusions	  per	  organoid	  than	  Msi1+/+	  mice	  (Figure	  2.7A).	  	  By	  day	  nine,	  
organoids	  were	  obscured	  from	  vision	  by	  dead	  debris	  in	  culture,	  so	  organoids	  were	  
passaged	  to	  allow	  for	  new	  protrusions	  to	  grow	  and	  be	  scored.	  	  Scoring	  commenced	  
immediately	  following	  passage	  and	  again	  Msi1-­‐/-­‐	  mice	  had	  less	  protrusions	  per	  
organoid	  than	  Msi1+/+	  mice	  (Figure	  2.7B).	  	  
	  
Apoptosis	  in	  the	  small	  intestine	  of	  Msi1-­/-­	  mice.	  
	  
Previous	  reports	  describe	  an	  increase	  in	  apoptosis	  upon	  conditional	  
knockout	  of	  APC	  in	  adult	  mice	  (4,	  19).	  	  Therefore,	  we	  hypothesized	  that	  elevated	  
levels	  of	  Apc	  would	  decrease	  apoptosis	  in	  Msi1-­‐/-­‐	  mice.	  	  In	  order	  to	  examine	  
apoptosis	  in	  these	  mice,	  western	  blot	  analysis	  of	  β-­‐fractin,	  a	  cleavage	  product	  of	  β-­‐
actin	  during	  apoptosis,	  were	  quantified	  in	  both	  genotypes.	  	  	  β-­‐fractin	  levels	  were	  
found	  to	  be	  decreased	  in	  Msi1-­‐/-­‐	  mice,	  though	  this	  trend	  did	  not	  reach	  significance	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   Previous	  work	  in	  the	  lab	  demonstrated	  a	  double-­‐negative	  feedback	  loop	  
between	  APC	  and	  MSI1	  in	  cell	  culture	  (8).	  	  However,	  the	  effects	  of	  this	  feedback	  loop	  
have	  not	  been	  demonstrated	  in	  intestinal	  tissue.	  	  In	  this	  study,	  we	  utilized	  a	  mouse	  
model	  generated	  in	  the	  Okano	  lab	  with	  ablated	  endogenous	  Msi1	  (10)	  in	  order	  to	  
study	  phenotypes	  related	  to	  Wnt	  signaling	  due	  to	  loss	  of	  Msi1	  in	  the	  intestine.	  	  Here	  
we	  present	  data	  for	  the	  small	  intestine	  that	  shows	  that	  Apc	  protein	  levels	  are	  up	  and	  
three	  Wnt	  target	  genes	  (cyclin-­D1,	  c-­myc,	  and	  axin-­2)	  are	  downregulated	  in	  the	  small	  
intestine.	  	  The	  absence	  of	  Msi1	  would	  be	  expected	  to	  alleviate	  translational	  
repression	  of	  Apc	  and	  Apc’s	  role	  as	  a	  downregulator	  of	  the	  canonical	  Wnt	  pathway	  
would	  explain	  the	  subsequent	  downregualtion	  of	  Wnt	  target	  genes.	  	  This	  data	  
implicates	  the	  Apc-­‐Msi1	  feedback	  loop	  in	  homeostasis	  of	  the	  small	  intestine.	  	  	  
Surprisingly,	  Hath1,	  a	  gene	  shown	  to	  be	  downregulated	  by	  canonical	  Wnt	  
signaling,	  did	  not	  show	  a	  response	  to	  increased	  levels	  of	  Apc	  protein.	  
Hath1	  was	  shown	  to	  be	  downregulated	  by	  the	  Wnt	  pathway	  (20)	  and	  was	  also	  
shown	  to	  be	  upregulated	  when	  a	  repressor	  of	  Notch,	  Numb,	  was	  knocked-­‐down	  in	  
colon	  cancer	  cell	  lines	  (21).	  	  Therefore,	  it	  would	  have	  been	  expected	  that	  elimination	  
of	  Msi1,	  which	  translationally	  represses	  Apc,	  thus	  downregulating	  the	  Wnt	  pathway	  
and	  Numb,	  which	  inhibits	  the	  Notch	  pathway,	  would	  result	  in	  an	  increase	  in	  Hath1	  
transcript.	  However,	  this	  was	  not	  seen.	  	  This	  result	  could	  be	  due	  to	  competition	  
between	  signaling	  pathways	  in	  the	  intestine.	  For	  instance,	  one	  study	  found	  that	  in	  
neural	  precursor	  cells,	  Hath1	  was	  upregulated	  by	  β-­‐catenin	  upon	  inhibition	  of	  Notch	  
signaling	  (22).	  In	  our	  system,	  Msi1	  knockout	  led	  to	  APC	  increase.	  Inhibition	  of	  β-­‐
catenin	  would	  be	  expected	  and	  thereby	  a	  decrease	  in	  Hath1	  transcription.	  However,	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it	  would	  also	  be	  predicted	  that	  Msi1	  knockout,	  leading	  to	  inhibition	  of	  Notch,	  would	  
upregulate	  Hath1.	  	  Therefore,	  these	  two	  regulatory	  mechanisms	  may	  compensate	  
for	  one	  another,	  leading	  to	  no	  change	  in	  Hath1	  overall.	  	  Further	  investigation	  into	  
the	  regulatory	  mechanisms	  underlying	  Hath1	  expression	  still	  need	  to	  be	  
investigated.	  	  	  
Other	  unexpected	  results	  included	  that	  proliferation	  of	  intestinal	  cells	  and	  
differentiation	  of	  goblet	  cells	  was	  unchanged	  in	  Msi1-­‐/-­‐	  mice.	  	  Proliferation	  is	  a	  
downstream	  effect	  of	  Wnt	  signaling	  and	  is	  usually	  restricted	  to	  the	  progenitor	  
compartment	  of	  the	  intestine.	  	  In	  Msi1-­‐/-­‐	  mice,	  it	  appeared	  that	  proliferating	  cells	  
were	  still	  maintained	  in	  the	  progenitor	  compartment	  and	  overall	  proliferation	  as	  
scored	  by	  Ki-­‐67	  staining	  was	  unchanged.	  	  In	  the	  future	  a	  secondary	  method	  of	  
assessing	  proliferation	  would	  need	  to	  be	  utilized	  such	  as	  injecting	  mice	  with	  BrdU,	  
which	  would	  allow	  for	  detection	  of	  cells	  entering	  S-­‐phase	  over	  a	  period	  of	  time.	  	  A	  
secondary	  method	  would	  yield	  more	  confidence	  in	  these	  results.	  	  
Goblet	  cell	  differentiation	  also	  showed	  no	  change	  in	  Msi1-­‐/-­‐	  mice.	  	  Goblet	  cells	  
have	  been	  shown	  to	  be	  lost	  upon	  conditional	  knockout	  of	  Apc	  in	  the	  small	  intestine	  
(4).	  Therefore,	  goblet	  cells	  would	  have	  been	  expected	  to	  increase	  due	  to	  increased	  
Apc	  protein	  levels	  in	  Msi1-­‐/-­‐	  mice.	  	  However,	  the	  number	  of	  alcian	  blue	  positive	  cells	  
was	  not	  found	  to	  change	  in	  these	  mice.	  	  Hath1	  has	  also	  been	  shown	  to	  be	  associated	  
with	  a	  goblet	  cell	  phenotype	  in	  the	  small	  intestine(23).	  	  In	  our	  previous	  experiment	  
of	  Wnt	  target	  gene	  levels,	  Hath1	  transcript	  levels	  were	  shown	  not	  to	  be	  affected	  by	  
loss	  of	  Msi1.	  Therefore,	  the	  connection	  between	  Hath1	  and	  goblet	  cells	  may	  not	  be	  
affected	  by	  loss	  of	  Msi1.	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Though	  proliferation	  and	  differentiation	  of	  goblet	  cells	  appeared	  to	  be	  
unaffected,	  loss	  of	  Msi1	  appeared	  to	  have	  a	  contradictory	  effect	  on	  crypt	  fission	  and	  
the	  number	  of	  protrusions/organoid	  in	  an	  ex	  vivo	  crypt	  culture.	  	  Crypt	  fission,	  an	  
indirect	  measurement,	  would	  be	  expected	  to	  decrease	  with	  loss	  of	  Msi1	  because	  of	  
Msi1’s	  role	  in	  stem	  cell	  division.	  	  However,	  it	  was	  observed	  during	  the	  crypt	  
isolation	  procedure	  that	  shaking	  the	  crypts	  from	  the	  small	  intestine	  may	  not	  have	  
produced	  whole	  crypts,	  but	  rather	  pieces	  of	  crypts.	  	  For	  the	  small	  intestine,	  it	  was	  
noticeably	  harder	  to	  dissociate	  crypts	  from	  surrounding	  tissue	  and	  more	  vigorous	  
dissociation	  methods	  had	  to	  be	  employed	  than	  in	  the	  colon.	  The	  method	  of	  isolating	  
crypts	  from	  the	  small	  intestine	  may	  have	  damaged	  crypts	  emerging	  and	  thereby	  
made	  scoring	  inaccurate.	  	  An	  alternative	  method	  to	  score	  crypt	  fission	  in	  the	  small	  
intestine	  should	  be	  sought.	  
Given	  the	  difficulties	  encountered	  when	  isolating	  whole	  crypts	  for	  crypt	  
fission	  analysis,	  a	  second	  method,	  an	  ex	  vivo	  culture	  system,	  was	  employed	  to	  
evaluate	  stem	  cell	  population	  differences	  between	  the	  two	  genotypes.	  	  This	  method	  
allows	  for	  crypts	  isolated	  from	  the	  small	  intestine	  to	  form	  organoids	  in	  culture.	  	  
These	  organoids	  will	  then	  grow	  crypt-­‐like	  protrusions	  from	  stem	  cells	  (17)	  and	  
protrusion	  number	  was	  scored	  as	  a	  way	  to	  capture	  differences	  between	  the	  
populations.	  	  The	  median	  number	  of	  protrusions	  from	  Msi-­‐/-­‐	  	  organoids	  was	  
consistently	  lower	  than	  from	  Msi+/+	  organoids	  over	  an	  eight	  day	  period.	  	  After	  
passaging,	  the	  median	  of	  the	  Msi-­‐/-­‐	  culture	  was	  relatively	  similar	  to	  that	  of	  the	  Msi+/+	  
culture,	  however,	  the	  number	  of	  organoids	  scored	  in	  the	  culture	  was	  very	  small	  (10	  
organoids	  on	  day	  15)	  and	  may	  not	  have	  been	  representative.	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Finally,	  decreased	  apoptosis	  in	  the	  Msi-­‐/-­‐	  	  mice	  was	  an	  unexpected	  finding.	  	  
Msi1	  knock-­‐down	  in	  HCT116	  cells	  	  showed	  an	  increase	  in	  apoptosis	  (24).	  	  However,	  
in	  these	  experiments,	  the	  HCT116	  cell	  line	  has	  a	  stabilizing	  mutation	  in	  β-­‐catenin	  
and	  therefore	  the	  Wnt	  pathway	  is	  constitutively	  activated.	  	  Therefore	  Msi1’s	  role	  in	  
apoptosis	  may	  have	  been	  through	  other	  pathways	  not	  related	  to	  Wnt	  signaling.	  
In	  summary,	  the	  Msi1/Apc	  double-­‐negative	  feedback	  loop	  appears	  to	  affect	  
the	  small	  intestine,	  though	  this	  effect	  does	  not	  fit	  with	  previously	  seen	  phenotypes	  
involving	  disruption	  of	  Wnt	  signaling.	  	  This	  study	  provides	  a	  starting	  point	  to	  
determine	  phenotypes	  associated	  with	  loss	  of	  this	  regulatory	  mechanism	  and	  in	  the	  
future	  could	  be	  used	  to	  understand	  the	  role	  of	  Msi1	  in	  an	  Apc-­‐mutant	  background.	  
In	  the	  next	  section,	  we	  will	  summarize	  the	  effects	  of	  loss	  of	  Msi1	  seen	  in	  the	  
colon	  as	  they	  are	  different	  than	  those	  found	  in	  the	  small	  intestine.	  A	  summary	  of	  
results	  found	  in	  both	  large	  and	  small	  intestine	  can	  be	  found	  in	  Table	  2.1.	  
	  





















Figure	  2.1.	  	  Apc	  protein	  levels	  in	  the	  small	  intestine.	  	  (A)	  Representative	  blots	  of	  Apc	  protein	  
levels	  in	  Msi1-­/-­	  mice.	  Apc	  levels	  were	  found	  to	  be	  higher	  in	  the	  small	  intestine	  of	  Msi1-­/-­	  mice,	  
although	  it	  did	  not	  reach	  statistical	  significance	  (p=	  0.185).	  	  	  (B)	  Protein	  was	  isolated	  from	  
epithelial	  cells	  of	  the	  small	  intestines	  of	  4	  Msi1+/+	  and	  10	  Msi1-­/-­	  mice.	  	  APC	  band	  intensities	  
were	  normalized	  to	  β-­actin	  and	  are	  presented	  as	  average	  fold	  change	  relative	  to	  Msi1+/+	  mice	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Figure	  2.2.	  	  Down	  regulation	  of	  Wnt	  target	  genes	  in	  the	  small	  intestine	  of	  Msi1-­/-­	  mice.	  Small	  
Intestinal	  epithelial	  cells	  were	  isolated	  from	  the	  small	  intestine	  of	  Msi1+/+	  mice	  and	  Msi1-­/-­	  
mice.	  	  For	  each	  sample,	  mRNA	  levels	  were	  examined	  for	  three	  genes	  upregulated	  by	  Wnt	  	  
signaling,	  c-­Myc,	  Axin2,	  and	  CyclinD1,	  by	  reverse	  transcriptase-­PCR.	  	  As	  controls,	  mRNA	  from	  
one	  gene	  not	  regulated	  by	  Wnt	  signaling,BTEB2,	  and	  one	  gene	  downregulated	  by	  Wnt	  
signaling,	  Hath1,	  were	  examined.	  	  Each	  gene	  was	  normalized	  to	  HGPRT,	  a	  housekeeping	  gene.	  	  
The	  results	  from	  5-­10	  mice	  are	  presented	  as	  the	  average	  mRNA	  fold	  change	  relative	  to	  Msi1+/+	  
mice	  +/-­	  s.e.m.	  P-­values	  <	  0.05	  as	  calculated	  by	  the	  Mann-­Whitney	  non-­parametric	  test	  are	  






























Figure	  2.3.	  	  Proliferation	  in	  the	  jejunum	  of	  Msi1-­/-­	  mice	  is	  unchanged	  compared	  to	  Msi1+/+	  mice.	  
(A)	  Representative	  images	  of	  cypts	  from	  Msi1+/+	  (left)	  and	  Msi1-­/-­	  (right)	  with	  the	  black	  line	  
indicating	  crypt	  border.	  	  Scale	  bar	  =	  10	  um	  (left	  panel).	  Jejunums	  were	  collected	  from	  4	  mice	  
of	  each	  genotype	  and	  paraffin	  embedded.	  	  48-­50	  crypts	  75um-­145um	  in	  length	  were	  scored	  
per	  mouse.	  (B)	  Data	  is	  presented	  as	  the	  average	  number	  of	  cells	  positive	  for	  proliferation	  
marker	  Ki67	  per	  crypt	  +/-­	  s.e.m	  for	  all	  samples.	  	  Proliferation	  differences	  between	  Msi1-­/-­	  
compared	  to	  Msi1+/+	  were	  found	  to	  not	  be	  significant	  (p-­value:	  0.564)	  as	  calculated	  by	  the	  

























Figure	  2.4.	  	  Goblet	  cell	  differentiation	  in	  the	  jejunum	  of	  Msi1-­/-­	  mice	  is	  unchanged	  compared	  to	  
Msi1+/+	  mice.	  Immunohistochemical	  analysis	  was	  performed	  on	  the	  jejunums	  of	  4	  Msi1+/+	  mice	  
and	  4	  Msi1-­/-­	  mice	  using	  Alcian	  blue	  staining	  as	  a	  marker	  for	  goblet	  cells.	  (A)	  Representative	  
images	  of	  isolated	  intestinal	  tissue	  from	  Msi1+/+	  and	  Msi1-­/-­	  mice	  stained	  with	  Alcian	  blue	  (left	  
panel).	  	  Scale	  bar	  =	  50	  um.	  	  The	  bottom	  183	  um	  of	  each	  villi	  were	  scored	  for	  alcian	  blue	  cells	  
and	  26-­58	  villi	  were	  scored	  in	  Msi1+/+	  mice	  and	  21-­68	  villi	  in	  Msi1-­/-­	  mice.	  (B)	  Data	  is	  
presented	  as	  the	  average	  of	  all	  data	  samples	  +/-­	  s.e.m.	  	  The	  average	  number	  of	  Goblet	  
cells/villi	  in	  Msi1+/+	  jejunum	  was	  found	  to	  not	  statistically	  differ	  compared	  to	  Msi1-­/-­	  jejunum	  

























Figure	  2.5.	  Elevation	  of	  Crypt	  fission	  in	  the	  small	  intestine	  of	  Msi1-­/-­	  mice.	  	  (A)	  Schematic	  of	  the	  
process	  of	  crypt	  fission.	  	  Fission	  is	  initiated	  when	  cypts	  reach	  a	  certain	  threshold	  of	  stem	  cells	  
where	  crypts	  bifurcate	  along	  the	  bottom	  and	  eventually	  split	  into	  two	  crypts.	  (B)	  
Representative	  images	  of	  crypts	  scored.	  	  Panel	  on	  the	  left	  is	  an	  image	  of	  a	  crypt	  not	  
undergoing	  fission	  while	  the	  panel	  on	  the	  right	  shows	  a	  crypt	  undergoing	  fission.	  (C)	  Crypts	  
were	  isolated	  from	  the	  small	  intestine	  via	  EDTA	  chelation	  and	  shaking	  and	  scored	  at	  160x	  for	  
fission.	  	  Data	  is	  presented	  as	  the	  average	  percent	  of	  crypts	  fissioning	  in	  the	  small	  intestine	  of	  5	  
Msi1+/+	  mice	  and	  3	  Msi1-­/-­	  mice	  +/-­	  the	  s.e.m.	  364-­736	  crypts	  scored	  were	  scored/mouse	  in	  	  
Msi1+/+	  mice	  and	  364-­736	  crypts/mouse	  scored	  in	  	  Msi1-­/-­	  mice.	  There	  were	  a	  higher	  percent	  
of	  crypts	  undergoing	  fission	  in	  Msi1-­/-­	  mice	  (p	  =	  0.0357)	  compared	  to	  Msi1+/+.	  P-­values	  <	  0.05	  





































Figure	  2.6.	  	  Crypt	  culture	  from	  Apc1322T/+	  mice	  produce	  more	  protrusion	  than	  Apc+/+.	  	  (A)	  A	  
schematic	  diagram	  of	  a	  crypt	  organoid	  adapted	  from	  Sato,	  T.,	  et	  al.	  (2009)	  Nature,	  459	  (7244),	  
262-­5.	  	  Villus	  domains	  contain	  all	  differentiated	  cells	  and	  crypt	  protrusions	  contains	  stem	  
cells.	  	  (B)	  To	  determine	  whether	  an	  ex	  vivo	  culture	  system	  would	  be	  an	  accurate	  measure	  of	  
stemness,	  we	  cultured	  crypts	  from	  an	  Apc1322T/+	  and	  Apc+/+	  mouse.	  	  	  In	  agreement	  with	  
previously	  published	  data,	  which	  show	  Apc1322T/+	  mice	  contain	  more	  stem	  cells	  in	  crypts,	  
organoids	  from	  Apc1322T/+	  produce	  more	  protrusions.	  	  Results	  are	  presented	  as	  the	  average	  












































































Figure	  2.7.	  Msi1-­/-­	  organoids	  have	  less	  protrusions	  than	  Msi1+/+	  organoids.	  	  Crypts	  
were	  isolated	  from	  one	  Msi1+/+	  and	  one	  Msi-­/-­	  mouse	  and	  grown	  in	  culture	  for	  a	  
total	  of	  15	  days.	  	  Crypts	  would	  form	  organoids	  that	  would	  make	  protrusions	  that	  
were	  then	  scored.	  (A)	  Results	  day	  1	  -­8	  after	  plating.	  	  Results	  are	  presented	  in	  a	  
box-­and-­whisker	  plot,	  and	  outliers	  4	  standard	  deviations	  away	  from	  the	  mean	  
were	  excluded	  but	  are	  displayed	  on	  graph.	  	  (B)	  	  Results	  after	  crypts	  were	  passaged	  
displayed	  in	  box-­and-­whisker	  plot.	  	  Outliers	  4	  standard	  deviations	  away	  from	  the	  




























Figure	  2.8.	  	  Apoptosis	  in	  the	  small	  intestine	  of	  Msi1-­/-­	  mice.	  (A)	  Representative	  blot	  showing	  
protein	  samples	  from	  both	  mice	  genotypes.	  Protein	  was	  isolated	  from	  epithelial	  cells	  of	  the	  
small	  intestines	  of	  4	  Msi1+/+	  and	  7	  Msi1-­/-­	  mice.	  	  (B)	  	  β-­fractin	  protein	  levels	  were	  normalized	  
to	  histone	  H2A.x,	  and	  are	  presented	  as	  average	  fold	  change	  relative	  to	  Msi1+/+	  mice	  +/-­	  s.e.m.	  	  
β-­fractin	  levels	  were	  found	  to	  be	  lower	  in	  the	  small	  intestine	  of	  Msi1-­/-­	  mice,	  although	  it	  did	  
not	  reach	  statistical	  significance	  (p=	  0.0545).	  P-­values	  <	  0.05	  as	  calculated	  by	  the	  Mann-­
Whitney	  non-­parametric	  test	  are	  considered	  significant.	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Results:	  Colon	  
	  
No	  significant	  change	  in	  Apc	  protein	  levels	  in	  the	  colon.	  
	  
To	  see	  how	  loss	  of	  Msi1affects	  Apc	  protein	  levels,	  we	  performed	  immunoblot	  
analysis	  using	  protein	  from	  the	  colons	  of	  Msi1-­‐/-­‐	  and	  Msi1+/+	  mice.	  	  We	  hypothesized	  
that	  there	  would	  be	  an	  increase	  in	  Apc	  levels	  in	  colons	  from	  Msi1-­‐/-­‐	  mice.	  	  Our	  
results	  showed	  that	  Apc	  levels	  were	  slightly	  elevated	  in	  colonic	  epithelial	  cells	  from	  
Msi-­‐/-­‐	  mice,	  but	  not	  significantly	  so	  (Figure	  2.9A	  and	  2.9B).	  
	  
No	  significant	  change	  in	  levels	  of	  Wnt	  target	  genes.	  
	  
As	  in	  the	  small	  intestine,	  we	  looked	  at	  upregulated	  Wnt	  target	  genes,	  c-­Myc,	  
axin-­2,	  and	  cyclin-­D1,	  downregulated	  Wnt	  target	  gene	  Hath1,	  and	  BTEB2	  mRNA	  
levels	  in	  the	  small	  intestine	  utilizing	  rt-­‐PCR	  (Figure	  2.10).	  	  C-­Myc,	  axin-­2,	  and	  cyclin-­
D1	  levels	  remained	  unchanged	  as	  did	  Hath1	  level.	  	  Interestingly,	  levels	  of	  BTEB2,	  a	  
non-­‐canonical	  Wnt	  target	  gene,	  were	  upregulated	  significantly.	  	  These	  results	  along	  
with	  the	  finding	  that	  Apc	  protein	  levels	  are	  unaffected,	  suggest	  that	  the	  Msi-­‐1/Apc	  
feedback	  loop	  may	  not	  play	  an	  integral	  role	  in	  large	  intestinal	  homeostasis.	  
	  
Proliferation	  in	  the	  colon	  of	  Msi1-­/-­	  mice	  is	  reduced.	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Though	  we	  found	  no	  evidence	  linking	  Msi1	  with	  Wnt	  signaling	  regulation	  in	  
the	  colon,	  Msi1	  likely	  has	  other	  functions	  in	  the	  colon.	  	  To	  examine	  functions	  of	  Msi1	  
in	  the	  colon,	  we	  first	  looked	  at	  the	  effects	  of	  Msi1	  loss	  on	  proliferation.	  	  Again,	  large	  
intestinal	  tissue	  was	  isolated	  from	  Msi1-­‐/-­‐	  mice	  and	  probed	  for	  Ki67,	  a	  proliferation	  
marker.	  	  There	  was	  a	  significant	  decrease	  in	  the	  number	  of	  Ki67-­‐positive	  cells	  per	  
crypt	  in	  the	  colons	  of	  Msi1-­‐/-­‐	  mice	  (Figure	  2.11A	  and	  2.11B).	  
	  
Crypt	  fission	  in	  the	  colon	  of	  Msi1-­/-­	  mice	  is	  reduced.	  	  
	  
Finding	  that	  proliferation	  was	  reduced,	  we	  next	  examined	  crypt	  fission	  in	  the	  
colons	  of	  Msi1-­‐/-­‐	  mice	  as	  well.	  	  It	  could	  be	  imagined	  that	  the	  level	  of	  proliferation	  
would	  correlate	  with	  crypt	  fission.	  Along	  this	  line	  of	  reasoning,	  we	  hypothesized	  
that	  fission	  would	  be	  reduced	  in	  the	  colons	  of	  Msi1-­‐/-­‐	  mice	  because	  proliferation	  
was	  reduced.	  	  To	  test	  this,	  we	  isolated	  crypts	  from	  colon	  tissue	  and	  examined	  them	  
for	  fissioning.	  	  We	  found	  the	  amount	  of	  crypt	  fissioning	  was	  significantly	  lower	  in	  
Msi1-­‐/-­‐	  mice	  than	  Msi1+/+	  (Figure	  2.12A	  and	  B).	  
	  
Apoptosis	  in	  the	  colon	  of	  Msi1	  -­/-­	  mice	  remains	  unchanged.	  
	  
	   Because	  there	  was	  decreased	  proliferation	  and	  crypt	  fission	  in	  colons	  of	  
Msi1-­‐/-­‐	  mice,	  we	  predicted	  that	  there	  would	  be	  a	  compensatory	  affect	  on	  apoptosis	  
as	  well.	  	  We	  collected	  protein	  from	  the	  colon	  of	  Msi1-­‐/-­‐	  mice	  and	  examined	  β-­‐fractin	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levels	  via	  immunoblot.	  	  	  β-­‐fractin	  	  levels	  remained	  unchanged	  in	  Msi1-­‐/-­‐	  as	  compared	  




	   The	  goal	  of	  this	  study	  was	  to	  correlate	  predicted	  consequences	  of	  the	  
Msi1/Apc	  double-­‐negative	  feedback	  loop	  with	  phenotypes	  found	  in	  the	  colons	  of	  
Msi1	  knockout	  mice.	  	  In	  this	  set	  of	  experiments,	  our	  results	  were	  found	  largely	  to	  
not	  be	  associated	  with	  results	  expected	  following	  disruption	  of	  the	  Apc/Msi1	  
double-­‐negative	  feedback	  loop.	  	  First,	  there	  was	  not	  a	  significant	  increase	  in	  Apc	  
protein	  level	  in	  colons	  from	  Msi1-­‐/-­‐	  mice.	  	  Second,	  the	  same	  three	  Wnt	  target	  genes,	  
cyclin-­D1,	  c-­myc,	  and	  axin-­2	  which	  are	  upregulated	  	  in	  canonical	  Wnt	  signaling,	  as	  
well	  as	  Hath1	  which	  is	  downregulated	  by	  canonical	  Wnt	  signaling	  were	  not	  
differentially	  expressed	  in	  the	  colons	  of	  Msi1-­‐/-­‐	  and	  Msi1+/+	  mice.	  	  However,	  BTEB2	  a	  
non-­‐canonical	  Wnt	  target	  was	  upregulated	  significantly	  in	  Msi1-­‐/-­‐	  mice.	  	  No	  previous	  
reports	  have	  connected	  BTEB2	  with	  Msi1	  so	  further	  investigation	  will	  be	  needed	  to	  
define	  this	  relationship.	  	  Our	  results	  support	  the	  idea	  that	  the	  Apc/Msi1	  double-­‐
negative	  feedback	  loop	  does	  not	  play	  an	  integral	  role	  in	  homeostasis	  of	  the	  mouse	  
colon	  and	  Msi1’s	  function	  in	  other	  signaling	  pathways	  such	  as	  Notch	  may	  be	  more	  
prominent	  in	  this	  tissue.	  
	   In	  support	  of	  the	  hypothesis	  that	  Msi1	  and	  its	  association	  with	  Notch	  have	  a	  
more	  prominent	  effect	  in	  the	  colon,	  proliferation	  and	  crypt	  fission	  were	  decreased	  
in	  colons	  from	  Msi1-­‐/-­‐	  mice.	  Previously,	  it	  was	  shown	  that	  loss	  of	  Numb,	  a	  target	  of	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translational	  inhibition	  of	  Msi1	  and	  an	  inhibitor	  of	  the	  Notch	  pathway,	  causes	  
proliferation	  in	  LS174T	  colon	  cancer	  cells	  (25).	  	  It	  is	  conceivable	  that	  in	  Msi1-­‐/-­‐	  mice,	  	  
alleviation	  of	  Msi1	  translational	  repression	  of	  Numb	  allows	  for	  repression	  of	  Notch	  
signaling	  and	  a	  subsequent	  decrease	  in	  cell	  proliferation.	  	  Crypt	  fission,	  which	  has	  
been	  thought	  to	  be	  linked	  to	  size	  of	  the	  crypt	  and	  stem	  cell	  number,	  would	  be	  
expected	  to	  be	  reduced	  in	  these	  mice	  which	  is	  corroborated	  by	  our	  data.	  
	   No	  change	  was	  found	  in	  the	  levels	  of	  β-­‐fractin,	  a	  protein	  cleaved	  during	  
apoptosis,	  between	  the	  two	  genotypes.	  	  β-­‐fractin	  has	  been	  shown	  to	  be	  a	  specific	  
marker	  of	  apoptosis	  in	  different	  cells	  of	  the	  nervous	  system	  (26).	  	  However,	  it	  has	  
not	  been	  tested	  in	  the	  intestine.	  	  Future	  studies	  should	  consider	  use	  of	  a	  different	  
marker	  of	  apoptosis,	  such	  as	  cleaved	  caspase	  3.	  
	   In	  summary,	  loss	  of	  Msi1	  in	  the	  colon	  of	  mice,	  appears	  to	  play	  a	  role	  
independent	  of	  the	  double-­‐negative	  feedback	  loop	  between	  Apc	  and	  Msi1	  that	  was	  
established	  in	  cultured	  colon	  cells.	  	  Apc	  protein	  levels	  as	  well	  as	  canonical	  Wnt	  
target	  genes	  were	  largely	  unaffected	  in	  colons	  of	  Msi1-­‐/-­‐	  mice.	  	  Cellular	  proliferation	  
and	  crypt	  fission	  appeared	  significantly	  decreased	  in	  Msi1-­‐/-­‐	  mice,	  however,	  these	  
phenotypes	  could	  be	  explained	  by	  the	  role	  of	  Msi1	  in	  the	  Notch	  signaling	  pathway.	  	  
Future	  studies	  investigating	  consequences	  of	  Apc/Msi1	  regulation	  using	  this	  mouse	  
model	  should	  focus	  on	  the	  small	  intestine	  and	  will	  ultimately	  clarify	  a	  role	  for	  
























Figure	  2.9.	  	  Apc	  protein	  levels	  in	  the	  colon.	  Apc	  protein	  levels	  were	  found	  to	  be	  unchanged	  in	  
the	  colon	  of	  Msi1-­/-­	  mice	  compared	  to	  Msi1+/+	  (p=0.41958).	  (A)	  Representative	  blot	  of	  Apc	  
protein	  levels	  in	  the	  colon.	  	  (B)	  Protein	  was	  isolated	  from	  epithelial	  cells	  of	  the	  colons	  of	  
Msi1+/+	  and	  Msi1-­/-­	  mice.	  	  Apc	  relative	  band	  intensities	  from	  4-­10	  mice	  were	  quantified,	  
normalized	  to	  β-­actin,	  and	  presented	  as	  average	  fold	  change	  relative	  compared	  to	  Msi1+/+	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Figure	  2.10.	  No	  significant	  difference	  in	  Wnt	  target	  genes	  in	  the	  colon	  of	  Msi1-­/-­	  mice.	  Large	  
intestinal	  epithelial	  cells	  were	  isolated	  from	  Msi1+/+	  mice	  and	  Msi1-­/-­	  mice.	  	  For	  each	  sample,	  
mRNA	  levels	  were	  examined	  for	  three	  genes	  upregulated	  by	  Wnt	  	  signaling,	  c-­Myc,	  Axin2,	  and	  
CyclinD1,	  by	  reverse	  transcriptase-­PCR.	  	  As	  controls,	  mRNA	  from	  one	  gene	  not	  regulated	  by	  
Wnt	  signaling,BTEB2,	  and	  one	  gene	  downregulated	  by	  Wnt	  signaling,	  Hath1,	  were	  examined.	  	  
Each	  gene	  was	  normalized	  to	  HGPRT,	  a	  housekeeping	  gene.	  	  The	  results	  from	  5-­10	  mice	  are	  
presented	  as	  the	  average	  mRNA	  fold	  change	  relative	  to	  Msi1+/+	  mice	  +/-­	  s.e.m.	  P-­values	  <	  0.05	  
as	  calculated	  by	  the	  Mann-­Whitney	  non-­parametric	  test	  are	  considered	  significant	  and	  are	  
indicated	  by	  an	  asterisk.	  
	  
	  

























Figure	  2.11.	  	  Proliferation	  in	  the	  colon	  of	  Msi1-­/-­	  mice	  is	  reduced	  compared	  to	  Msi1+/+	  mice.	  (A)	  
Representative	  images	  of	  cypts	  from	  Msi1+/+	  (left)	  and	  Msi1-­/-­	  (right)	  with	  the	  black	  line	  
indicating	  crypt	  border.	  	  Scale	  bar	  =	  10	  um	  (left	  panel).	  (B)	  Samples	  were	  collected	  from	  4	  
mice	  of	  each	  genotype	  and	  27-­100	  crypts	  75um-­145um	  in	  length	  were	  scored	  per	  mouse.	  Data	  
is	  presented	  as	  the	  average	  number	  of	  cells	  positive	  for	  proliferation	  marker	  Ki67	  per	  crypt	  
+/-­	  s.e.m	  for	  all	  samples.	  	  Proliferation	  was	  decreased	  in	  Msi1-­/-­	  mice	  compared	  to	  Msi1+/+	  (p-­
























Figure	  2.12.	  Decreased	  Crypt	  fission	  in	  the	  colon	  of	  Msi1-­/-­	  mice.	  	  	  Crypts	  were	  isolated	  from	  the	  
colon	  using	  EDTA	  chelation	  and	  shaking	  and	  scored	  at	  160x	  for	  fission.	  	  (A)	  Representative	  
image	  of	  a	  crypt	  not	  fissioning	  (panel	  on	  the	  left)	  and	  a	  crypt	  fissioning	  (panel	  on	  the	  right).	  
(B)	  Data	  is	  presented	  as	  the	  average	  percent	  of	  crypts	  fissioning	  in	  the	  colon	  of	  5	  Msi1+/+	  mice	  
and	  4	  Msi1-­/-­	  mice	  +/-­	  the	  s.e.m.	  364-­736	  crypts	  scored	  were	  scored/mouse	  in	  	  Msi1+/+	  mice	  
and	  523-­826	  crypts/mouse	  scored	  in	  	  Msi1-­/-­	  mice.	  There	  were	  a	  lower	  percent	  of	  crypts	  
undergoing	  fission	  in	  Msi1-­/-­	  mice	  (p	  =	  0.0317)	  compared	  to	  Msi1+/+.	  P-­values	  <	  0.05	  as	  
calculated	  by	  the	  Mann-­Whitney	  non-­parametric	  test	  are	  considered	  significant.	  	  Significant	  
values	  indicated	  by	  an	  asterisk.	  
	  
	  























Figure	  2.13.	  	  Apoptosis	  in	  the	  colon	  of	  Msi1-­/-­	  mice.	  (A)	  Representative	  blot	  of	  β-­fractin	  protein	  
levels	  in	  the	  colon.	  Protein	  was	  isolated	  from	  epithelial	  cells	  of	  the	  colons	  of	  4	  Msi1+/+	  and	  7	  
Msi1-­/-­	  mice.	  (B)	  β-­fractin	  protein	  levels	  were	  normalized	  to	  histone	  H2A.x,	  and	  are	  presented	  
as	  average	  fold	  change	  relative	  to	  Msi1+/+	  mice	  +/-­	  s.e.m.	  	  β-­fractin	  levels	  were	  found	  to	  be	  
unchanged	  in	  the	  colon	  of	  Msi1-­/-­	  mice	  (p=	  0.324).	  P-­values	  <	  0.05	  as	  calculated	  by	  the	  Mann-­
Whitney	  non-­parametric	  test	  are	  considered	  significant.	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Summary	  of	  Results	  
	   APC	  and	  its	  canonical	  role	  as	  a	  negative	  regulator	  of	  Wnt	  signaling	  has	  been	  
extensively	  studied.	  	  Loss	  of	  APC	  has	  been	  shown	  to	  be	  a	  critical	  initiating	  step	  in	  
colorectal	  tumorigenesis	  and	  treatment	  strategies	  that	  can	  be	  devised	  to	  
compensate	  for	  the	  loss	  of	  this	  critical	  gatekeeper	  gene	  are	  needed.	  	  Our	  lab	  
previously	  showed	  that	  translation	  of	  APC	  is	  inhibited	  by	  MSI1.	  	  MSI1	  also	  has	  been	  
shown	  to	  play	  a	  crucial	  role	  in	  maintaining	  stemness	  characteristics	  in	  progenitor	  
cell	  populations	  through	  activation	  of	  both	  the	  Wnt	  and	  Notch	  signaling	  pathways	  
(1,	  2)	  and	  is	  upregulated	  in	  colorectal	  cancer	  in	  both	  mouse	  models	  and	  humans	  (3,	  
4).	  	  Our	  lab	  and	  another	  lab,	  has	  shown	  MSI1	  to	  be	  a	  Wnt	  target	  (1,	  5,	  6)	  and	  
expression	  of	  MSI1	  inhibits	  APC	  expression,	  promoting	  Wnt	  signaling.	  	  The	  
implications	  of	  disruption	  of	  this	  double	  negative	  feedback	  regulation	  are	  important	  
considerations	  before	  utilizing	  this	  regulatory	  mechanism	  as	  a	  potential	  target	  for	  
treatment	  in	  tissues	  that	  lack	  functional	  APC.	  	  The	  work	  in	  this	  thesis	  has	  focused	  on	  
consequent	  changes	  in	  intestinal	  tissue	  homeostasis	  that	  result	  from	  germ-­‐line	  
knock-­‐out	  of	  Msi1	  in	  mice,	  with	  particular	  emphasis	  on	  proliferation	  and	  
differentiation.	  We	  have	  shown	  that	  in	  the	  small	  intestine,	  proliferation	  and	  
differentiation	  are	  unaltered	  in	  mice	  lacking	  Msi1.	  	  However,	  Apc	  protein	  levels	  
were	  seen	  to	  increase	  and	  Wnt	  target	  genes,	  especially	  those	  linked	  to	  proliferation,	  
Cyclin	  D1	  and	  c-­‐Myc	  were	  seen	  to	  decrease.	  	  These	  results	  suggest	  that	  at	  the	  
molecular	  level,	  the	  Apc-­‐Msi1	  double-­‐negative	  feedback	  loop	  was	  disrupted.	  	  Fission	  
events	  and	  crypt	  protrusion	  growth	  were	  also	  affected,	  though	  in	  different	  ways	  and	  
apoptosis	  was	  decreased.	  	  In	  the	  large	  intestine,	  Apc	  and	  Wnt	  target	  genes	  were	  not	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affected	  by	  Msi1	  knockout,	  indicating	  that	  perhaps	  in	  this	  tissue	  Msi1	  plays	  a	  more	  
prominent	  role	  in	  other	  signaling	  pathways	  such	  as	  Notch.	  	  Proliferation	  was	  found	  
to	  significantly	  decrease	  and	  apoptosis	  remained	  unaffected.	  
	   Disruption	  of	  the	  double-­‐negative	  feedback	  loop	  between	  Apc	  and	  Msi1	  
should	  have	  an	  impact	  on	  different	  cellular	  phenotypes	  depending	  on	  how	  this	  
regulation	  is	  altered.	  	  In	  colorectal	  cancer	  for	  instance,	  with	  loss	  of	  functional	  APC,	  
Msi1,	  as	  a	  Wnt	  target	  gene	  would	  be	  highly	  expressed	  and	  cellular	  proliferation	  and	  
a	  stem-­‐like	  state	  would	  be	  favored.	  	  Evidence	  supporting	  this	  includes	  that	  Msi1	  
levels	  as	  well	  as	  proliferation	  were	  shown	  to	  be	  elevated	  in	  small	  intestine	  upon	  
conditional	  knockout	  of	  Apc	  in	  a	  mouse	  model	  (4).	  	  Msi1	  overexpression	  has	  also	  
been	  directly	  linked	  to	  high	  proliferation	  and	  expansion	  of	  progenitor	  populations	  
(1).	  	  Also,	  Lgr5+	  progenitor	  cells,	  a	  progenitor	  where	  Msi1	  is	  expressed,	  were	  shown	  
to	  be	  able	  to	  cause	  adenomas	  upon	  conditional	  loss	  of	  APC	  (7).	  At	  the	  other	  extreme,	  
where	  Msi1	  is	  absent	  from	  the	  feedback	  loop,	  APC	  levels	  should	  be	  high	  and	  
phenotypes	  associated	  with	  differentiation	  and	  quiescence	  would	  be	  favored.	  	  	  
However,	  because	  our	  data	  indicate	  that	  phenotypes	  related	  to	  proliferation	  
and	  differentiation	  remained	  unaffected	  in	  mouse	  small	  intestine,	  the	  critical	  nature	  
of	  this	  feedback	  loop	  may	  only	  be	  apparent	  upon	  cellular	  stress.	  	  Msi1	  knockout	  
mice	  develop	  neural	  phenotypes	  but	  otherwise	  are	  unaffected	  by	  germ-­‐line	  
knockout	  of	  this	  gene	  (8).	  	  If	  Msi1	  played	  a	  critical	  role	  in	  intestinal	  homeostasis,	  a	  
more	  severe	  phenotype	  would	  be	  expected	  in	  the	  intestine.	  	  Also,	  Msi1	  knock-­‐down	  
has	  previously	  been	  shown	  to	  only	  elicit	  an	  effect	  in	  colon	  cancer	  cell	  lines	  and	  
xenografts	  (9).	  	  And,	  Msi1	  was	  found	  to	  be	  	  tumorigenic	  in	  normal	  intestinal	  
	   68	  
epithelia	  cells	  only	  upon	  high	  over-­‐expression	  (1).	  	  Therefore,	  phenotypes	  related	  to	  
loss	  of	  Msi1	  in	  the	  intestine	  may	  depend	  upon	  induction	  of	  stress.	  	  
Alternatively,	  effects	  of	  the	  Apc	  /	  Msi1	  double-­‐negative	  feedback	  regulation	  
may	  be	  more	  integral	  in	  the	  stem-­‐cell	  compartment	  of	  the	  intestine,	  and	  the	  method	  
of	  using	  the	  whole	  intestine	  to	  dissect	  out	  phenotypes	  related	  to	  this	  feedback	  loop	  
may	  not	  be	  sensitive	  enough.	  	  Msi1	  expression	  is	  restricted	  mainly	  to	  the	  progenitor	  
compartment	  (10),	  therefore	  the	  APC-­‐Msi1	  regulation	  is	  probably	  more	  critical	  in	  
this	  compartment.	  	  By	  isolating	  epithelial	  cells	  from	  the	  whole	  intestine,	  	  the	  effects	  
of	  APC-­‐Msi1	  regulation	  may	  be	  diluted.	  	  	  
	   Msi1	  plays	  an	  important	  role	  in	  signaling	  pathways	  integral	  to	  the	  
maintenance	  of	  intestinal	  epithelia.	  	  Msi1	  plays	  a	  role	  in	  activating	  Notch	  signaling	  
through	  inhibition	  of	  m-­‐Numb	  (11).	  	  Along	  with	  Wnt	  signaling,	  Notch	  is	  involved	  in	  
promoting	  proliferation	  in	  the	  progenitor	  compartment	  and	  allowing	  for	  
differentiation	  between	  absorptive	  and	  secretory	  lineages	  further	  up	  the	  crypt	  (12).	  	  
Msi1	  plays	  a	  role	  in	  activating	  Wnt	  signaling,	  another	  pathway	  needed	  to	  promote	  
stemness	  in	  progenitors,	  through	  inhibition	  of	  Apc	  (6).	  	  Though	  these	  two	  pathways	  
are	  both	  important	  and	  Msi1	  was	  found	  to	  be	  an	  activator	  of	  both,	  the	  activation	  of	  
these	  pathways	  by	  Msi1	  are	  two	  independent	  events	  (1).	  	  Therefore,	  it	  is	  
conceivable	  that	  both	  pathways	  may	  have	  different	  levels	  of	  importance	  in	  different	  
tissues.	  	  In	  the	  large	  intestine,	  mucus	  producing	  cells	  are	  especially	  important	  for	  
facilitating	  the	  removal	  of	  dehydrated	  waste	  and	  are	  at	  increased	  numbers	  
compared	  with	  the	  small	  intestine.	  	  Notch	  signaling	  has	  been	  shown	  to	  be	  integral	  
for	  goblet	  cell	  fate	  determination	  (13-­15).	  Activation	  of	  Notch	  has	  been	  shown	  to	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deplete	  goblet	  cells	  (15);	  inhibition	  of	  Notch	  promotes	  goblet	  cell	  differentiation	  (13,	  
14).	  	  As	  a	  regulator	  of	  Notch,	  Msi1	  therefore	  may	  have	  a	  more	  prominent	  role	  in	  
helping	  to	  establish	  secretory	  cell	  fate	  in	  the	  large	  intestine	  and	  thereby	  its	  role	  in	  
Wnt	  signaling	  may	  be	  overshadowed.	  	  In	  this	  study,	  scoring	  differentiation	  of	  goblet	  
cells	  was	  unsuccessful.	  	  Alcian	  blue	  staining,	  which	  was	  used	  previously	  to	  mark	  
goblet	  cells,	  did	  not	  yield	  specific	  staining.	  	  Future	  studies	  will	  be	  required	  to	  
distinguish	  the	  roles	  played	  by	  Msi1	  in	  both	  tissues	  in	  order	  to	  link	  cellular	  




My	  studies	  have	  highlighted	  some	  of	  the	  cellular	  phenotypes	  associated	  with	  
germ-­‐line	  knockout	  of	  Msi1	  and	  the	  effects	  of	  this	  knockout	  on	  Wnt	  signaling	  in	  the	  
intestine.	  	  However,	  there	  are	  still	  studies	  that	  need	  to	  be	  undertaken	  to	  further	  
connect	  Msi1	  and	  Apc	  in	  the	  small	  intestine	  and	  the	  implications	  of	  this	  negative	  
feedback	  loop	  on	  intestinal	  homeostasis.	  
I	  would	  propose	  to	  further	  develop	  the	  project	  that	  I	  have	  presented	  in	  this	  
dissertation	  by	  expanding	  studies	  of	  the	  various	  phenotypes	  presented	  here.	  	  First,	  I	  
only	  present	  data	  for	  differentiation	  of	  one	  cell	  type	  of	  the	  secretory	  lineage,	  Goblet	  
cells,	  in	  the	  small	  intestine.	  	  It	  has	  been	  shown	  that	  Msi1	  expression	  in	  LS174T	  cells	  
can	  suppress	  paneth	  cell	  specific	  markers	  (16).	  	  However,	  this	  study	  also	  showed	  
that	  markers	  related	  to	  other	  cell	  types	  were	  unaffected	  by	  Msi1	  expression.	  	  
Therefore,	  Msi1	  knockout	  may	  have	  an	  effect	  on	  paneth	  cell	  differentiation	  to	  a	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higher	  degree	  than	  other	  cell	  types.	  	  To	  compliment	  the	  Ki-­‐67	  analysis,	  injecting	  
mice	  with	  BrdU	  and	  then	  staining	  tissue	  to	  identify	  positive	  cells	  would	  be	  a	  
secondary	  way	  to	  show	  proliferation.	  	  Because	  loss	  of	  Apc	  and	  overexpression	  of	  
Msi1	  both	  have	  shown	  to	  be	  connected	  to	  increases	  in	  proliferation	  and	  our	  study	  
currently	  shows	  no	  difference	  in	  proliferation	  in	  the	  small	  intestine,	  a	  secondary	  
method	  would	  allow	  for	  more	  confidence	  in	  the	  data	  presented.	  	  Along	  with	  
proliferation,	  apoptosis	  should	  be	  assessed	  by	  a	  secondary	  method.	  	  Commonly,	  
apoptosis	  is	  assessed	  by	  immunohistochemistry	  for	  activated	  caspase	  3	  and	  this	  
method	  may	  detect	  apoptosis	  more	  directly.	  	  Also,	  a	  direct	  method	  to	  assess	  stem	  
cell	  numbers	  in	  the	  crypt	  needs	  to	  be	  established.	  	  Our	  methods	  of	  scoring	  organoid	  
protrusions	  as	  well	  as	  fission	  to	  determine	  stem	  cell	  number	  are	  indirect	  and	  need	  
to	  be	  corroborated	  with	  direct	  evidence	  regarding	  stem	  cell	  number.	  	  Though	  
staining	  for	  specific	  stem	  cell	  markers	  was	  unsuccessful	  in	  the	  current	  study,	  other	  
methods	  are	  present	  to	  assess	  stem	  cell	  number.	  	  For	  instance,	  real-­‐time	  
quantitative	  PCR	  could	  be	  performed	  to	  assess	  the	  amount	  of	  transcript	  for	  either	  
Lgr5	  or	  Bmi1	  both	  of	  which	  mark	  stem	  cell	  populations	  in	  the	  intestine.	  	  Finally,	  a	  
direct	  method	  to	  establish	  involvement	  of	  the	  Apc/Msi1	  negative	  feedback	  
mechanism	  with	  Wnt	  and	  Notch	  signaling	  in	  the	  intestine	  should	  be	  pursued.	  	  	  For	  
the	  small	  intestine,	  to	  determine	  whether	  Wnt	  signaling	  is	  activated,	  nuclear	  
localization	  of	  β-­‐catenin	  could	  be	  compared	  between	  Msi1-­‐/-­‐	  and	  Msi1+/+	  mice.	  
Reduced	  levels	  of	  nuclear	  β-­‐catenin	  would	  indicate	  less	  Wnt	  signaling.	  	  In	  the	  large	  
intestine,	  reduction	  of	  Notch	  target,	  Hes1,	  would	  show	  that	  loss	  of	  Msi1	  affected	  
Notch	  signaling.	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Along	  with	  further	  examining	  the	  double-­‐negative	  feedback	  loop	  in	  tissue	  of	  
Msi1-­‐/-­‐	  mice,	  it	  would	  be	  critical	  to	  identify	  whether	  this	  double-­‐negative	  feedback	  
loop	  is	  important	  in	  cancerous	  tissue.	  	  Specifically,	  does	  manipulation	  of	  this	  
feedback	  loop	  by	  removing	  Msi1	  from	  the	  tissue	  allow	  for	  reduction	  of	  tumors?	  	  To	  
this	  end,	  we	  are	  currently	  breeding	  Msi1-­‐/-­‐	  mice	  with	  ApcMin/+	  mice.	  	  We	  hypothesize	  
that	  these	  double-­‐mutant	  mice	  will	  have	  a	  reduced	  tumor	  burden	  as	  compared	  to	  
the	  ApcMin/+	  mice.	  	  
To	  examine	  the	  effects	  of	  Msi1	  and	  Apc	  in	  cancerous	  tissue	  at	  the	  molecular	  
level,	  the	  crypt	  culturing	  system	  could	  be	  used.	  	  ApcMin/+	  or	  Apc1322T/+	  crypts	  could	  be	  
grown	  and	  knock-­‐down	  of	  Msi1	  using	  siRNA	  could	  be	  employed.	  The	  examination	  of	  
effects	  	  in	  Apc1322T/+	  crypts	  upon	  loss	  of	  Msi1	  would	  be	  particularly	  pertinent	  to	  the	  
role	  of	  Msi1	  in	  stem	  cells	  because	  in	  this	  mouse	  model	  the	  stem	  cell	  number	  is	  
increased	  (17).	  If	  Msi1	  knockdown	  had	  an	  effect	  on	  reducing	  stemness	  of	  these	  
organoids,	  this	  would	  lend	  support	  for	  its	  possible	  use	  as	  a	  target	  for	  cancer	  therapy.	  
Finally,	  it	  would	  be	  interesting	  to	  determine	  whether	  other	  mechanisms	  
contributed	  to	  the	  reduction	  of	  proliferation	  in	  the	  colon	  aside	  from	  Wnt	  signaling	  
or	  Notch	  signaling.	  Msi1	  has	  been	  shown	  to	  downregulate	  levels	  of	  p21waf1,	  a	  
repressor	  of	  cyclin-­‐dependent	  kinases,	  and	  overexpression	  of	  Msi1	  was	  shown	  to	  
allow	  for	  enhanced	  S-­‐phase	  entry	  (18).	  	  So,	  knockout	  of	  Msi1	  may	  lead	  to	  an	  
upregulation	  of	  p21waf1,	  which	  would	  allow	  for	  the	  decrease	  seen	  in	  the	  proliferation	  
in	  the	  colon.	  	  So,	  Msi1’s	  role	  in	  cell-­‐cycle	  regulation	  would	  be	  an	  avenue	  of	  research	  
to	  explore.	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In	  summary,	  the	  Apc-­‐Msi1	  double	  negative	  feedback	  loop	  was	  examined	  in	  the	  
intestinal	  tissue	  of	  Msi1-­‐/-­‐	  mice.	  	  Data	  from	  the	  small	  intestine	  fit	  our	  hypothesis	  that	  
disruption	  of	  this	  regulatory	  mechanism	  would	  reduce	  Wnt	  signaling.	  	  However,	  
some	  phenotypes	  associated	  with	  Wnt	  signaling	  were	  unaffected.	  	  In	  the	  large	  
intestine,	  loss	  of	  Msi1	  had	  no	  apparent	  affect	  on	  Apc	  levels	  or	  most	  phenotypes	  
associated	  with	  Wnt	  signaling.	  	  Future	  studies	  will	  need	  to	  further	  examine	  the	  
importance	  of	  this	  regulatory	  mechanism	  in	  tissue	  and	  determine	  whether	  this	  
regulation	  is	  important	  in	  cancerous	  tissues.	  	  With	  further	  understanding,	  Msi1,	  via	  
its	  role	  in	  this	  feedback	  loop,	  may	  be	  an	  important	  target	  for	  future	  colon	  cancer	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Abstract	  
	  
Adenomatous	  polyposis	  coli	  (APC)	  and	  topoisomerase	  IIα	  (topo	  IIα)	  have	  been	  
shown	  by	  our	  lab	  to	  interact	  and	  have	  an	  influence	  on	  the	  G2/M	  transition	  in	  the	  cell	  
cycle.	  	  However,	  only	  the	  central	  portion	  of	  the	  APC	  protein	  was	  examined	  for	  topo	  
IIα	  interaction	  and	  whether	  other	  portions	  of	  the	  APC	  protein	  have	  an	  interaction	  
with	  topo	  IIα	  remains	  unknown.	  	  Also,	  whether	  truncated	  APC	  in	  colon	  cancer	  will	  
interact	  with	  topo	  IIα	  has	  yet	  to	  be	  tested.	  To	  further	  characterize	  interactions	  of	  
APC	  and	  topo	  IIα,	  we	  introduced	  a	  nuclear	  localization	  signal	  onto	  APC	  domains	  that	  
had	  not	  been	  previously	  examined	  because	  of	  their	  cytoplasmic	  localization	  and	  
showed	  that	  these	  constructs	  successfully	  localize	  to	  the	  nucleus.	  However,	  binding	  
interactions	  with	  topo	  IIα	  still	  need	  to	  be	  established.	  We	  also	  examined	  whether	  
endogenous	  truncated	  APC	  found	  in	  HT29	  cells	  interacted	  with	  topo	  IIα.	  	  We	  found	  
that	  a	  truncation	  containing	  the	  M2	  portion	  of	  APC	  does	  interact	  with	  topo	  IIα	  while	  
a	  shorter	  truncation	  encompassing	  the	  N-­‐terminal	  portion	  of	  APC	  does	  not	  show	  
interaction	  with	  topo	  IIα.	  Through	  further	  characterization	  of	  topo	  IIα/APC	  
interactions,	  more	  complete	  understanding	  of	  how	  these	  proteins	  work	  together	  to	  
regulate	  the	  cell	  cycle	  can	  be	  achieved,	  ultimately	  determining	  if	  misregulation	  
caused	  by	  truncated	  APC	  interacting	  with	  topo	  IIα	  contributes	  to	  the	  pathogenesis	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Topoisomerase	  IIα	  (topo	  IIα),	  an	  enzyme	  integral	  to	  cell	  cycle	  progression,	  is	  
over-­‐expressed	  in	  many	  colorectal	  cancers	  (1).	  	  The	  normal	  function	  of	  	  topo	  IIα	  is	  
to	  allow	  for	  detanglement	  of	  DNA	  during	  cell	  replication,	  transcription,	  and	  
metaphase	  in	  actively	  growing	  cells	  (2),	  and	  topo	  IIα	  expression	  is	  normally	  
restricted	  to	  the	  proliferative	  zone	  in	  the	  colon(1).	  Topo	  IIα	  is	  involved	  in	  DNA	  
decatenation	  by	  introducing	  a	  transient	  double	  strand	  break	  in	  the	  DNA	  and	  then	  
undergoing	  a	  conformational	  change	  that	  allows	  for	  passage	  of	  a	  second	  DNA	  to	  
relieve	  entanglement(2).	  If	  topo	  IIα	  is	  not	  functioning	  properly,	  then	  cells	  halt	  at	  the	  
G2/M	  decatenation	  checkpoint	  (3).	  
APC	  has	  also	  been	  shown	  to	  play	  an	  active	  role	  in	  the	  cell	  cycle.	  	  A	  previous	  
study	  showed	  that	  when	  APC	  was	  ectopically	  expressed	  in	  a	  colon	  cancer	  cell	  line	  
with	  mutant	  APC,	  cells	  arrested	  at	  G1	  due	  to	  repression	  of	  Wnt	  target	  Cyclin	  D1(4).	  	  
Also,	  zinc	  chloride	  treatment	  of	  a	  colon	  cancer	  cell	  line	  expressing	  full-­‐length	  APC	  
caused	  arrest	  in	  the	  G2/M	  phase	  of	  the	  cell	  cycle	  (5).	  	  Previously,	  our	  lab	  showed	  
that	  APC	  present	  in	  the	  nucleus	  allowed	  for	  G2/M	  arrest	  by	  interacting	  with	  topo	  
IIα.	  Exogenously	  expressed	  pieces	  of	  APC,	  M2-­‐APC	  (amino	  acids	  999-­‐1326)	  and	  M3-­‐
APC	  (amino	  acids	  1327-­‐2058),	  interacted	  with	  topo	  IIα	  and	  lead	  to	  altered	  nuclear	  
morphology,	  accumulation	  of	  cells	  in	  the	  G2	  phase	  of	  the	  cell	  cycle,	  and	  altered	  
decatenation	  activity	  (6,	  7).	  	  However,	  whether	  the	  other	  portions	  of	  the	  APC	  
protein,	  including	  the,	  NT,	  M1,	  and	  CT	  fragments,	  would	  interact	  with	  topo	  IIα	  and	  
whether	  these	  interactions	  would	  affect	  the	  cell	  cycle	  remained	  unknown.	  	  Also,	  
whether	  topo	  IIα	  interacts	  with	  truncated	  APC	  expressed	  in	  colon	  cancer	  cells	  was	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unknown.	  	  Here,	  we	  show	  in	  HT29	  cells	  that	  the	  longer	  endogenous	  APC	  truncated	  
protein,	  amino	  acids	  1-­‐1555	  which	  contains	  the	  M2	  portion	  of	  APC,	  interacts	  with	  
topo	  IIα	  while	  the	  shorter	  truncation	  in	  the	  same	  cell	  line,	  which	  includes	  only	  the	  
N-­‐terminal	  portion	  of	  APC,	  does	  not.	  	  Also,	  we	  show	  that	  when	  NT,	  M1,	  and	  CT	  
fragments	  are	  fused	  to	  a	  nuclear	  localization	  signal,	  they	  can	  successfully	  translocate	  
into	  the	  nucleus.	  	  The	  interaction	  of	  these	  APC	  fragments	  with	  topo	  IIα	  still	  needs	  to	  
be	  investigated.	  	  Finally,	  a	  list	  of	  procedures	  tested	  while	  optimizing	  the	  co-­‐
immunoprecipitation	  of	  NLS-­‐APC	  fragments	  is	  provided.	  
	  
Materials	  and	  Methods	  
	  
Cell	  Culture.	  
HCT116βw	  cells	  were	  provided	  by	  Dr.	  Bert	  Vogelstein	  and	  grown	  in	  McCoy’s	  5A	  
with	  10%	  fetal	  bovine	  serum.	  HT29	  cells	  were	  purchased	  from	  ATCC	  and	  were	  
grown	  in	  McCoy’s	  5A	  with	  10%	  fetal	  bovine	  serum.	  	  
	  
Cloning	  of	  NLS	  into	  APC	  expression	  constructs.	  
Expression	  constructs	  for	  APC	  fragments	  fused	  to	  GFP,	  NT-­‐APC,	  M1-­‐APC,	  M2-­‐APC,	  
M3-­‐APC,	  CT-­‐APC,	  were	  provided	  by	  Dr.	  Naoki	  Watanabe	  and	  described	  in	  (8).	  	  The	  
nuclear	  localization	  signal	  from	  SV40	  virus	  large	  T	  antigen	  was	  cloned	  upstream	  of	  	  
the	  APC	  gene	  using	  the	  following	  primers:	  upstream:	  5’	  TGC	  GGA	  GGA	  TGC	  CCA	  AAA	  
AAG	  AAG	  A	  3’,	  downstream:	  5’	  TCG	  ACG	  TCT	  ACC	  TTT	  CTC	  TTC	  TTT	  3’.	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Transfection.	  
HCT116	  β/w	  cells	  at	  50%	  confluence	  were	  transfected	  with	  16	  µg	  of	  NLS	  APC	  
expression	  plasmids	  or	  GFP	  plasmid	  with	  GeneExpresso	  reagent	  (Lab	  Supply	  Mall)	  
at	  a	  ratio	  of	  1	  µg	  DNA	  :	  3.5	  µL	  of	  reagent	  in	  10	  cm	  cell	  culture	  dishes.	  	  Transfection	  
reagent	  was	  prepared	  by	  adding	  GeneExpresso/DNA	  solution	  to	  McCoy’s	  5A	  /	  10%	  
fetal	  bovine	  serum	  and	  then	  added	  to	  cells.	  	  Cells	  were	  grown	  for	  48	  hours	  following	  
transfection	  before	  harvesting	  for	  protein	  analysis.	  	  	  
	  	  	  	  
Coimmunoprecipitation	  of	  Endogenous	  truncated	  APC	  and	  topo	  IIα.	  
Immunoprecipitation	  was	  performed	  using	  a	  modified	  protocol	  from	  Invitrogen	  
Dynabeads.	  	  Cells	  at	  90%	  confluence	  were	  lysed	  in	  lysis	  buffer	  (50	  mM	  Tris	  pH	  7.5,	  
0.1%	  NP40,	  100	  mM	  NaCl,	  1	  mM	  MgCl2,	  5	  mM	  EDTA,	  1:7	  Roche	  EDTA-­‐free	  (cat.	  no.	  
04693159001)	  	  protease	  inhibitor,	  1:100	  Halt	  phosphatase	  inhibitor	  (cat	  no.	  78420)	  
in	  1x	  PBS)	  on	  ice	  for	  5	  minutes.	  	  The	  entire	  procedure	  was	  performed	  at	  4°C.	  Cell	  
lysates	  were	  filtered	  twice	  by	  passing	  lysate	  through	  a	  QIAshredder	  (Qiagen	  cat.	  no.	  
79654)	  and	  centrifuging	  at	  9300	  g	  to	  rupture	  cells	  and	  shred	  DNA.	  	  Antibodies	  
including,	  4	  μg	  	  APC-­‐M2	  	  (Wang	  et	  al.	  2009)	  and	  4	  μg	  	  rabbit	  IgG	  (Sigma)	  were	  pre-­‐
incubated	  with	  protein	  A	  magnetic	  Dynabeads	  (Invitrogen)	  for	  10	  minutes.	  One	  
milligram	  of	  soluble	  lysate	  was	  added	  to	  antibody	  saturated	  Dynabeads	  and	  
incubated	  at	  2	  hours	  with	  rotation.	  	  Supernatant	  was	  removed	  from	  beads	  and	  
added	  to	  beads	  pre-­‐incubated	  with	  50	  μg	  	  of	  ALI1228	  antibody	  (Chemicon	  cat.	  no.	  
MAB3785)	  specific	  for	  the	  N-­‐terminal	  portion	  of	  APC.	  This	  reaction	  was	  allowed	  to	  
incubate	  for	  2	  hours	  with	  rotation.	  	  In	  order	  to	  remove	  immunoprecipitated	  protein,	  
	   80	  
beads	  were	  subjected	  to	  two	  washes	  of	  PBS	  containing	  protease	  and	  phosphatase	  
inhibitors	  followed	  by	  heating	  at	  95°C	  in	  5x	  sample	  buffer	  to	  dissociate	  protein	  from	  
the	  beads.	  	  All	  samples	  were	  stored	  at	  -­‐80°C	  until	  further	  use.	  	  See	  protocol	  below	  
for	  a	  more	  detailed	  description	  of	  procedure.	  	  
	  
Invitrogen	  Protocol	  with	  modifications	  
Solutions	  needed:	  	  	  
1. Lysis	  buffer:	  	  	  
50	  mM	  Tris	  pH	  7.5,	  0.1%	  NP40,	  100	  mM	  NaCl,	  1	  mM	  MgCl2,	  5	  mM	  
EDTA,	  1:7	  Roche	  protease	  inhibitor,	  1:100	  Halt	  phosphatase	  inhibitor	  
in	  1x	  PBS	  
2. 0.02%	  Tween	  20	  in	  PBS	  
3. PBS	  (with	  protease	  and	  phosphatase	  inhibitor):	  
	  1x	  PBS	  	  with1:7	  Roche	  protease	  inhibitor,	  1:100	  Halt	  phosphatase	  
inhibitor	  added.	  
4. 5x	  SDS	  loading	  buffer	  (see	  protein	  analysis	  Results	  for	  list	  of	  components).	  
	  
Preparation	  of	  Protein	  A	  Dynabeads	  (Invitrogen	  cat.	  no.	  10002D)	  	  	  
1. resuspend	  Dynabeads	  by	  flicking	  container.	  
2. transfer	  50	  μL	  Dynabeads	  to	  microfuge	  tube.	  
3. place	  tube	  on	  magnet	  to	  separate	  the	  beads	  from	  the	  solution,	  and	  remove	  
the	  supernatant.	  
4. removed	  tube	  from	  magnet.	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Binding	  of	  Antibody	  
5. add	  antibody	  to	  200	  μL	  PBS	  with	  0.02%	  Tween	  20.	  
6. Incubate	  with	  rotator	  10	  min.	  
7. Place	  tube	  on	  magnet	  and	  remove	  supernatant	  –	  supernatant	  may	  be	  kept	  for	  
further	  analysis.	  
8. Remove	  tube	  from	  magnet	  and	  resuspend	  beads-­‐antibody	  complex	  in	  200	  μL	  
PBS	  with	  Tween	  20.	  
	  
Preparation	  of	  Cell	  lysate	  (Anna	  Wang’s	  adapted	  protocol)	  	  
Procedure	  performed	  on	  ice	  or	  at	  4°C	  
1. Add	  1	  mL	  lysis	  buffer	  to	  cells	  both	  HCT116	  cells	  and	  HT29	  cells	  grown	  to	  
80-­‐90%	  confluence	  and	  incubate	  5	  min.	  
2. Pass	  sample	  through	  Qiashreder	  filter	  in	  microfuge	  tube,	  spin	  down	  
10,000	  rpm,	  2	  min,	  resuspend,	  repeated	  twice.	  
3. 	  Resuspend	  and	  collect	  65	  μL	  sample	  and	  label	  whole	  cell	  lysate.	  
4. spin	  down	  samples	  10,600	  rpm,	  20	  min.	  to	  pellet	  insoluble	  material.	  
5. remove	  supernatant	  into	  separate	  microfuge	  tube,	  keep	  pellet	  and	  label	  
insoluble.	  
6. read	  protein	  concentration	  of	  supernatant	  (soluble	  fraction)	  on	  nanodrop	  
OD280.	  
7. collect	  65	  μL	  sample	  from	  soluble	  fraction	  –	  label	  SL	  (soluble	  lysate).	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Immunoprecipitation	  
8. put	  beads	  on	  magnet,	  remove	  supernatant	  and	  discard,	  remove	  beads	  
from	  magnet.	  
9. add	  1	  mg	  of	  soluble	  fraction	  protein	  to	  beads	  and	  pipette	  up	  and	  down	  to	  
resuspend	  –	  (calculation:	  1mg/concentration	  of	  soluble	  lysate	  =	  volume	  
of	  soluble	  fraction	  to	  add	  to	  beads	  in	  mL)	  
10. incubate	  2	  hours	  on	  rotator	  4C	  
11. place	  tubes	  on	  magnet	  and	  transfer	  65	  μL	  of	  supernatant	  to	  new	  
microfuge	  tube	  –	  label	  supernatant,	  discard	  extra	  supernatant	  
12. Wash	  dynabeads-­‐antibody-­‐antigen	  complex	  three	  times	  using	  200	  μL	  of	  
PBS	  with	  protease	  and	  phosphatase	  inhibitors	  for	  each	  wash.	  	  Separate	  on	  
the	  magnet	  between	  each	  wash,	  remove	  supernatant	  and	  resuspend	  by	  
gentle	  pipeting.	  
13. Resuspend	  Dynabeads-­‐antibody-­‐antigen	  complex	  in	  100	  μL	  PBS	  and	  
transfer	  bead	  suspension	  to	  a	  clean	  tube.	  
14. Put	  tube	  on	  magnet,	  remove	  supernatant,	  add	  65	  μL	  of	  PBS	  with	  protease	  
and	  phosphatase	  inhibitors	  and	  35	  μL	  of	  SDS	  loading	  buffer.	  
15. Add	  35	  μL	  SDS	  loading	  buffer	  to	  all	  samples.	  
16. Heat	  all	  samples	  5	  min,	  100°C.	  
17. Put	  tubes	  on	  magnet,	  remove	  supernatant	  to	  new	  tubes	  –	  label	  PD	  (pull-­‐
down),	  discard	  beads.	  
18. Vortex	  all	  samples	  30	  seconds.	  
19. Heat	  all	  samples	  5	  minutes,	  100°C.	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20. Vortex	  briefly,	  store	  at	  -­‐80°C	  
	  
Protein	  analysis	  for	  NLS-­APC-­GFP	  transfected	  constructs	  
Primary	  antibody	  used	  for	  immunoprecipitation	  was	  4	  µg	  of	  rabbit	  anti-­‐GFP	  
(Invitrogen)	  for	  all	  experimental	  conditions,	  unless	  otherwise	  stated.	  	  Modified	  
Invitrogen	  protocol	  was	  used	  for	  all	  conditions	  unless	  otherwise	  stated.	  
	  
Procedure1:	  Covalent	  conjugation	  of	  beads	  to	  antibody	  followed	  by	  IP:	  
Protein	  A	  dynabeads	  were	  washed	  twice	  with	  1x	  PBS	  and	  antibody	  was	  incubated	  
for	  2	  hours	  with	  the	  beads	  at	  room	  temperature.	  	  Beads	  conjugated	  to	  antibody	  
were	  then	  washed	  twice	  with	  0.2M	  triethanol	  amine	  pH	  8.0.	  	  One	  mg	  of	  DMP	  was	  
added	  and	  solution	  was	  immediately	  rotated	  for	  15	  minutes.	  	  100	  μL	  of	  1M	  Tris	  pH	  
8.0	  was	  added	  to	  the	  solution	  and	  the	  solution	  was	  rotated	  for	  2	  hours.	  	  The	  beads	  
were	  washed	  twice	  with	  1x	  PBS,	  then	  washed	  with	  1/10x	  PBS,	  then	  1	  mL	  of	  0.2M	  
Glycine	  pH	  2	  twice,	  followed	  by	  PBS-­‐T	  (1x	  PBS	  with	  10mM	  Tris	  pH	  8)	  three	  times.	  	  	  	  	  
	   Preparation	  of	  cell	  lysate	  and	  immunoprecipitation	  were	  done	  as	  above	  at	  
4°C.	  	  Following	  immunoprecipitation,	  beads	  were	  washed	  with	  cell	  lysis	  buffer	  twice	  
for	  15	  minutes	  each	  followed	  by	  two	  washes	  with	  PBS	  15	  minutes	  each	  and	  protein	  
was	  removed	  from	  beads	  as	  described	  above.	  
	  
Procedure	  2:	  Use	  of	  Invitrogen	  protocol	  with	  modifications	  
Modified	  Invitrogen	  protocol	  above	  was	  used.	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Procedure	  3:	  Use	  of	  lithium	  chloride	  or	  lysis	  buffer	  washes	  to	  remove	  non-­‐specific	  
binding	  from	  the	  beads	  
After	  immunoprecipitation	  with	  cell	  lysate,	  beads	  were	  divided	  in	  half	  and	  one	  set	  of	  
beads	  was	  washed	  twice	  with	  500	  mM	  lithium	  chloride	  the	  other	  set	  was	  washed	  
once	  with	  lysis	  buffer	  followed	  by	  a	  wash	  with	  500	  mM	  lithium	  chloride.	  	  Protein	  
was	  removed	  from	  beads	  as	  above.	  
	  
Procedure	  4:	  	  Blocking	  the	  antibody-­‐complexed	  beads	  with	  5%	  gelatin.	  
After	  binding	  of	  beads	  to	  antibody,	  5%	  gelatin	  was	  added	  to	  the	  antibody-­‐
complexed	  beads	  and	  incubated	  for	  30	  minutes	  to	  block	  antibody-­‐complexed	  beads.	  	  
The	  rest	  of	  the	  procedure	  was	  repeated	  as	  above.	  
	  
Procedure	  5:	  	  Use	  of	  a	  different	  GFP	  antibody	  
4	  μg	  of	  The	  GFP	  antibody	  (rabbit	  anti-­‐GFP,	  GeneScript	  cat.	  no.	  A017045)	  was	  
incubated	  with	  the	  beads	  and	  the	  rest	  of	  the	  procedure	  was	  repeated	  as	  above.	  
	  
Procedure	  6:	  Use	  of	  DNase	  to	  remove	  DNA	  contamination	  
Following	  immunoprecipitation,	  beads	  were	  incubated	  in	  5U	  DNase	  for	  15	  minutes	  
at	  room	  temperature.	  	  The	  beads	  were	  then	  washed	  as	  described	  above	  and	  rest	  of	  
procedure	  was	  followed.	  
	  
Procedure	  7:	  Pre-­‐clearing	  the	  lysate	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Modified	  Invitrogen	  protocol	  was	  used.	  	  In	  order	  to	  pre-­‐clear	  the	  cell	  lysate,	  10	  mg	  
of	  rabbit	  IgG	  antibody	  were	  added	  to	  the	  beads	  and	  incubated	  for	  10	  minutes.	  	  The	  
cell	  lysate	  was	  incubated	  with	  IgG-­‐beads	  for	  2	  hours	  at	  4°C.	  	  The	  beads	  were	  
removed,	  and	  the	  immunoprecipitation	  experiment	  was	  performed	  as	  above.	  
	  
Immunoblot	  analysis	  
Immunoblots	  for	  coimmunoprecipitation	  of	  endogenous	  APC	  and	  topo	  IIα	  were	  
blocked	  in	  5%	  milk	  TBS-­‐T	  and	  were	  probed	  with	  the	  following	  antibodies:	  rabbit	  
anti-­‐human	  topo	  IIα	  antibody	  (Azuma	  lab)	  1:1000,	  APC-­‐M2	  1:3000,	  ALI12-­‐28	  1:100.	  	  
Secondary	  antibodies	  used	  included:	  horseradish	  peroxidase	  goat	  anti-­‐rabbit	  IgG	  
(Bio-­‐Rad	  cat.	  No.	  172-­‐1019)	  and	  HRP-­‐rabbit	  anti-­‐mouse	  IgGγ	  (Zymed	  cat.	  no.	  61-­‐
6020).	  	  Blots	  were	  developed	  using	  SuperSignal	  West	  Femto	  Maximum	  Sensitivity	  
Substrate	  (Pierce)	  and	  a	  Kodak	  Image	  Station	  4000R.	  Experiment	  was	  repeated	  on	  
three	  separate	  occasions	  with	  the	  same	  results.	  
	   Immunoblot	  for	  coimmunoprecipitation	  of	  APC	  constructs	  and	  topo	  IIα	  was	  
performed	  as	  above	  and	  blots	  were	  probed	  with	  the	  following	  primary	  antibodies:	  
Rabbit	  anti-­‐GFP	  (Invitrogen)	  1:1000	  and	  rabbit	  anti-­‐human	  topo	  IIα	  antibody	  
(Azuma	  lab)	  1:1000.	  Secondary	  antibodies	  included:	  horseradish	  peroxidase	  goat	  
anti-­‐rabbit	  IgG	  (Bio-­‐Rad	  cat.	  No.	  172-­‐1019)	  and	  cleanblot	  IP	  detection	  reagent	  (HP)	  
(Thermo	  Scientific).	  
	  
Imaging	  for	  Nuclear	  localization	  of	  APC.	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Examination	  of	  subcellular	  localization	  of	  NLS-­‐APC-­‐GFP	  was	  performed	  using	  a	  
Nikon	  Eclipse	  TE3000-­‐U	  	  inverted	  microscope	  at	  400x	  magnification	  and	  images	  




The	  N-­terminal	  portion	  of	  APC	  does	  not	  interact	  with	  topoisomerase	  IIα.	  
Previously,	  our	  lab	  has	  shown	  that	  exogenously	  expressed	  central	  portions	  of	  
APC	  referred	  to	  as	  APC-­‐M2	  and	  APC-­‐M3,	  bind	  to	  topo	  IIα	  and	  regulate	  its	  activity	  (6,	  
7).	  	  Because	  M2	  is	  maintained	  in	  the	  truncated	  APC	  found	  in	  many	  colorectal	  
cancers,	  we	  wanted	  to	  determine	  if	  different	  endogenous	  APC	  truncations	  interacted	  
with	  topo	  IIα.	  	  To	  this	  end,	  we	  used	  HT29	  cells,	  a	  colorectal	  cancer	  cell	  line	  that	  
expresses	  two	  endogenous	  truncated	  APC	  fragments	  (tAPC).	  tAPC1555	  contains	  the	  
M2	  portion	  of	  the	  protein	  and	  tAPC853	  lacks	  any	  previously	  shown	  Apc/topo	  IIα	  
binding	  regions	  (Fig	  app.	  1.1A).	  	  We	  hypothesized	  that	  tAPC1555	  would	  show	  an	  
interaction	  with	  topo	  IIα	  in	  HT29	  cells	  but	  did	  not	  know	  whether	  topo	  IIα	  could	  
interact	  with	  tAPC853.	  	  In	  order	  to	  determine	  whether	  these	  different	  truncations	  of	  
APC	  bound	  to	  topo	  IIα,	  coimmunoprecipitation	  was	  performed	  using	  an	  antibody	  
specific	  for	  the	  M2	  portion	  of	  APC.	  	  	  This	  procedure	  allowed	  for	  the	  cell	  lysate	  to	  be	  
immuno-­‐depleted	  of	  tAPC1555	  leaving	  behind	  tAPC853.	  	  	  tAPC853	  was	  then	  
immunoprecipitated	  with	  an	  antibody	  specific	  for	  the	  N-­‐terminal	  portion	  APC.	  	  
Immunoblot	  analysis	  was	  performed	  to	  determine	  whether	  topo	  IIα	  
coimmunoprecipitated	  with	  either	  APC	  truncation	  (Fig.	  app.	  1.1B).	  	  As	  expected	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based	  on	  our	  previous	  binding	  studies,	  tAPC1555	  coimmunoprecipitated	  with	  topo	  
IIα.	  	  Both	  truncations	  of	  APC	  precipitated	  with	  the	  M2	  antibody,	  likely	  because	  they	  
can	  form	  dimers	  via	  an	  N-­‐terminal	  dimerization	  domain.	  	  Topo	  IIα	  did	  not	  co-­‐
precipitate	  with	  APC853.	  
	  
Methods	  attempted	  to	  coimmunoprecipitate	  NLS-­NT-­APC,	  NLS-­M1-­APC,	  and	  NLS-­CT-­
APC	  with	  topo	  IIα.	  	  
Previously,	  our	  lab	  has	  shown	  that	  M2-­‐APC	  and	  M3-­‐APC	  localize	  to	  the	  
nucleus	  and	  coimmunoprecipitates	  with	  topo	  IIα.	  	  However,	  expression	  of	  M2-­‐APC	  
and	  M3-­‐APC	  had	  differential	  effects	  on	  the	  cells	  and	  topo	  IIα	  activity.	  	  These	  effects	  
included	  altered	  nuclear	  morphology,	  extent	  of	  G2	  cell	  cycle	  accumulation,	  
decatenation	  activity	  of	  topo	  IIα,	  as	  well	  as	  the	  amount	  of	  topo	  IIα	  that	  was	  
precipitated	  with	  each	  construct	  (6,	  7).	  	  These	  observations	  led	  to	  the	  hypothesis	  
that	  different	  portions	  of	  APC	  may	  interact	  with	  topo	  IIα	  in	  different	  ways.	  	  In	  order	  
to	  test	  this	  hypothesis,	  the	  other	  APC-­‐GFP	  constructs	  were	  examined	  for	  
coimmunoprecipitation	  with	  topo	  IIα.	  	  These	  constructs	  had	  not	  been	  previously	  
used	  for	  coimmunoprecipitation	  because	  they	  did	  not	  localize	  to	  the	  nucleus	  and	  
therefore	  were	  not	  expected	  to	  interact	  with	  topo	  IIα.	  	  However,	  it	  had	  not	  been	  
shown	  whether	  these	  APC	  domains,	  if	  they	  were	  to	  localize	  to	  the	  nucleus,	  could	  
interact	  with	  topo	  IIα.	  	  To	  facilitate	  nuclear	  localization	  of	  these	  APC	  domains,	  we	  
made	  constructs	  	  that	  express	  the	  NLS	  from	  Simian	  Virus	  40	  (SV40)	  large	  T	  antigen	  
fused	  with	  the	  N-­‐terminus	  of	  various	  APC	  fragments	  linked	  to	  green	  fluorescent	  
protein	  (GFP)	  and	  transfected	  these	  constructs	  into	  HCT116	  cells.	  	  Each	  APC	  domain	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appeared	  to	  localize	  to	  the	  nucleus	  of	  live	  cells	  (fig	  app	  1.2A).	  	  	  We	  also	  successfully	  
immunoprecipitated	  these	  constructs	  from	  HCT116	  cell	  lysates	  using	  a	  GFP	  
antibody	  (fig	  app	  1.2B).	  	  However,	  upon	  probing	  the	  blot	  for	  topo	  IIα,	  we	  found	  topo	  
IIα	  precipitating	  with	  the	  GFP	  antibody	  in	  cells	  transfected	  with	  GFP	  alone.	  	  We	  also	  
found	  full-­‐length	  APC	  precipitating	  with	  GFP	  antibody	  in	  both	  cells	  transfected	  with	  
GFP	  and	  M2-­‐APC	  (fig	  app	  1.2C).	  	  	  	  
	   These	  results	  lead	  to	  a	  series	  of	  experiments	  designed	  to	  reduce	  non-­‐specific	  
binding	  to	  the	  GFP	  antibody	  used	  to	  immunoprecipitate	  the	  APC	  domains	  from	  cell	  
lysates.	  	  A	  summary	  of	  the	  methods	  used	  is	  listed	  in	  Appendix	  Table	  1.	  	  All	  
optimization	  strategies	  attempted	  still	  yielded	  non-­‐specific	  binding	  in	  the	  
coimmunoprecipitations	  so	  were	  not	  further	  pursued.	  	  First,	  an	  entirely	  new	  
protocol	  from	  Invitrogen,	  was	  used	  with	  modifications	  for	  the	  immunoprecipitation.	  	  
The	  original	  protocol	  (see	  Materials	  and	  Methods	  protein	  analysis	  for	  NLS-­‐APC-­‐GFP	  
constructs	  procedure	  1)	  covalently	  conjugated	  the	  GFP	  antibody	  to	  the	  magnetic	  
beads	  and	  yielded	  non-­‐specific	  binding.	  	  The	  Invitrogen	  protocol	  with	  modifications	  
(see	  Materials	  and	  Methods	  protein	  analysis	  for	  NLS-­‐APC-­‐GFP	  constructs	  procedure	  
2)	  was	  used	  successfully	  in	  the	  previous	  experiment	  to	  precipitate	  endogenous	  APC	  
from	  HT29	  cell	  lysates	  but	  was	  unsuccessful	  when	  used	  for	  immunoprecipitation	  
with	  the	  GFP	  antibody.	  	  Modifications	  were	  then	  made	  to	  the	  Invitrogen	  protocol.	  	  
The	  first	  modification	  was	  to	  wash	  the	  beads	  following	  immunoprecipitation	  with	  
lithium	  chloride	  or	  lysis	  buffer	  to	  detach	  non-­‐specific	  materials	  adhering	  to	  the	  
beads	  (see	  Materials	  and	  Methods	  protein	  analysis	  for	  NLS-­‐APC-­‐GFP	  constructs	  
procedure	  3).	  	  These	  washes	  are	  far	  more	  stringent	  than	  PBS	  but	  were	  still	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unsuccessful	  at	  eliminating	  the	  non-­‐specific	  binding	  to	  the	  GFP	  antibody.	  	  Next,	  5%	  
gelatin	  was	  used	  to	  block	  the	  GFP-­‐conjugated	  beads	  (see	  Materials	  and	  Methods	  
protein	  analysis	  for	  NLS-­‐APC-­‐GFP	  constructs	  procedure	  4).	  	  The	  next	  modification	  
included	  pre-­‐clearing	  the	  lysate	  from	  the	  cells	  using	  an	  IgG	  antibody	  conjugated	  to	  
beads	  in	  order	  to	  remove	  non-­‐specific	  protein	  before	  the	  immunoprecipitation	  was	  
performed	  (see	  Materials	  and	  Methods	  protein	  analysis	  for	  NLS-­‐APC-­‐GFP	  constructs	  
procedure	  5).	  	  Finally,	  removal	  of	  potential	  DNA	  contamination	  from	  the	  
immunoprecipitated	  material	  was	  attempted	  (see	  Materials	  and	  Methods	  protein	  
analysis	  for	  NLS-­‐APC-­‐GFP	  constructs	  procedure	  6).	  	  This	  modification	  was	  




APC	  has	  many	  other	  roles	  in	  the	  cell	  in	  addition	  to	  its	  role	  in	  regulation	  of	  
canonical	  Wnt	  signaling.	  	  Namely,	  our	  lab	  showed	  that	  APC	  has	  a	  function	  in	  cell-­‐
cycle	  regulation	  via	  its	  interaction	  with	  topo	  IIα.	  	  Specifically,	  full-­‐length	  
endogenous	  APC	  was	  shown	  to	  coimmunoprecipitate	  with	  topo	  IIα	  and	  the	  M2	  and	  
M3	  portions	  were	  shown	  to	  interact	  with	  topo	  IIα	  and	  affect	  topo	  IIα	  activity	  (6,	  7).	  	  
However,	  it	  was	  unknown	  whether	  truncated	  APC	  from	  colon	  cancer	  cell	  lines	  
interacted	  with	  topo	  IIα	  and	  whether	  other	  portions	  of	  APC	  aside	  from	  the	  central	  
portion	  could	  interact	  with	  topo	  IIα.	  	  We	  show	  here	  that	  a	  long	  endogenous	  
truncation	  of	  APC	  containing	  the	  M2	  portion	  of	  the	  protein	  coimmunoprecipitated	  
with	  topo	  IIα.	  	  A	  shorter	  truncation	  containing	  only	  the	  N-­‐terminal	  portion	  of	  the	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protein	  did	  not	  coprecipitate	  with	  topo	  IIα.	  	  We	  also	  have	  introduced	  a	  nuclear	  
localization	  signal	  into	  the	  NT-­‐APC,	  M1-­‐APC,	  and	  CT-­‐APC	  expression	  constructs	  for	  
future	  analysis	  of	  specific	  APC	  domains.	  	  This	  work	  suggests	  that	  longer	  forms	  of	  
endogenous	  truncated	  APC	  do	  interact	  with	  topo	  IIα	  and	  that	  further	  work	  needs	  to	  
be	  done	  to	  establish	  whether	  other	  portions	  of	  APC	  interact	  with	  topo	  IIα.	  	  
There	  are	  many	  avenues	  to	  be	  pursued	  with	  this	  project.	  	  One	  potential	  
project	  would	  be	  to	  determine	  co-­‐localization	  of	  the	  NLS-­‐APC	  fragments	  with	  
endogenous	  topo	  IIα	  using	  fluorescence microscopy and Förster resonance energy 
transfer (FRET) analysis as an alternative method to complement	  the	  
immunoprecipitation	  results.	  Another	  pressing	  question	  is	  whether	  the	  interaction	  
between	  topo	  IIα	  and	  truncated	  APC	  makes	  colorectal	  cancers	  more	  resistant	  to	  
treatments	  with	  common	  chemotherapeutic	  reagents,	  such	  as	  etoposide,	  which	  acts	  
as	  a	  topo	  IIα	  poison.	  	  In	  a	  colon	  cancer	  cell,	  if	  truncated	  APC	  binds	  to	  topo	  IIα	  and	  
renders	  it	  inactive,	  then	  it	  would	  be	  expected	  that	  etoposide	  would	  be	  ineffective,	  
since	  this	  class	  of	  topo	  IIα	  poisons	  depends	  on	  active	  topo	  IIα	  to	  kill	  cells.	  	  Colon	  
cancers	  are	  commonly	  resistant	  to	  treatment	  with	  topo	  IIα	  poisons	  (9),	  and	  it	  would	  
be	  interesting	  to	  determine	  whether	  truncated	  APC	  helps	  promote	  this	  resistance.	  	  If	  
such	  a	  role	  for	  truncated	  APC	  is	  found,	  we	  envision	  developing	  small	  molecules	  to	  



















































Appendix	  figure	  1.1.	  tAPC1555	  co-­precipitates	  with	  topo	  IIα	  while	  tAPC853	  does	  not.	  	  (A)	  
Diagram	  of	  truncated	  APC	  in	  HT29	  cells	  with	  one	  allele	  that	  is	  853	  amino	  acids	  in	  length	  
and	  the	  second	  allele	  on	  bottom	  that	  is	  1555	  amino	  acids	  in	  length.	  	  Along	  the	  top	  are	  the	  
different	  APC	  constructs	  including	  NT	  (amino	  acid	  1-­20),	  M1	  (amino	  acid	  221-­958),	  M2	  
(amino	  acid	  959-­1338),	  M3	  (amino	  acid	  1211-­2075),	  and	  CT	  (amino	  acid	  2076-­2843).	  	  
(B)	  Co-­immunoprecipitation	  of	  both	  truncated	  APC	  proteins	  endogenous	  to	  HT29	  cells,	  
tAPC853	  and	  tAPC1555,	  with	  topo	  IIα.	  tAPC1555	  was	  precipitated	  from	  the	  soluble	  lysate	  (SL)	  
using	  an	  antibody	  specific	  for	  the	  M2	  portion	  of	  APC	  (M2-­APC).	  This	  
immunoprecipitation	  (IP)	  is	  labeled	  as	  M2S	  (M2	  supernatant)	  and	  M2P	  (M2	  pull-­down)	  
on	  the	  blot.	  This	  IP	  was	  followed	  by	  a	  second	  immunoprecipitation	  of	  tAPC853	  from	  the	  
M2S	  lysate	  with	  an	  antibody,	  ALI12-­28,	  specific	  for	  the	  N-­terminal	  portion	  of	  APC	  
(labeled	  ALS	  for	  supernatant	  and	  ALP	  for	  pull-­down).	  IgG	  IP	  was	  used	  as	  a	  control.	  M2	  IP	  
with	  M2-­APC	  shows	  that	  both	  truncated	  APC	  proteins	  precipitate	  as	  well	  as	  topo	  IIα.	  	  IP	  
with	  ALI12-­28	  shows	  that	  tAPC853	  precipitates	  but	  topo	  IIα	  does	  not.	  	  HCT116β/w	  cells	  
were	  used	  as	  a	  control	  reaction	  and	  show	  that	  M2-­APC	  antibody	  can	  precipitate	  full-­
length	  APC	  and	  topo	  IIα.	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Appendix	  figure	  1.2.	  	  NLS	  fusions	  facilitated	  nuclear	  localization	  of	  APC	  domains,	  however	  
coimmunoprecipitation	  of	  constructs	  was	  unsuccessful.	  	  (A)	  The	  NLS	  from	  SV40	  large	  T	  
antigen	  was	  cloned	  upstream	  of	  NT-­APC,	  M1-­APC,	  and	  CT-­APC	  and	  fusions	  were	  expressed	  
in	  HCT116	  β/w	  cells.	  	  Live	  images	  were	  acquired	  at	  400x.	  	  Scale	  bar	  =	  50	  μm.	  	  (B)	  	  
Immunoblot	  showing	  that	  all	  APC	  domains	  were	  immunoprecipitated	  from	  HCT116	  β/w	  
using	  a	  GFP	  antibody.	  	  (C)	  Cells	  transfected	  with	  M2-­GFP	  construct	  (positive	  control)	  and	  
GFP	  alone	  (negative	  control)	  show	  topo	  IIα	  in	  both	  positive	  and	  negative	  control.	  	  Full-­
length	  APC	  was	  also	  present	  in	  both	  positive	  and	  negative	  control.	  	  HCT116	  β/w	  cells	  were	  
transfected	  with	  each	  construct	  and	  protein	  was	  harvested	  48	  hours	  after	  transfection.	  	  
Immunoprecipitation	  was	  performed	  with	  a	  GFP	  antibody	  and	  blots	  were	  probed	  for	  full-­
length	  APC	  using	  APC-­M2	  antibody,	  for	  topo	  IIα,	  and	  for	  M2-­APC-­GFP	  and	  GFP	  using	  a	  GFP	  
antibody.	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